[
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "llama-2-7b-chat-hf_response": "Acrokeratosis paraneoplastica is also known as Ackr.",
    "llama-2-7b-chat-hf_fact_raw": "1. Acrokeratosis paraneoplastica is synonymously known as Ackr.",
    "llama-2-7b-chat-hf_fact": [
      "Acrokeratosis paraneoplastica is synonymously known as Ackr."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Acrokeratosis paraneoplastica is synonymously known as Bazex syndrome.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "llama-2-7b-chat-hf_response": "No, Weaver syndrome is different from Sotos syndrome. While both are genetic disorders that affect brain development, Weaver syndrome is characterized by intellectual disability, seizures, and distinctive facial features, while Sotos syndrome is characterized by intellectual disability, growth delays, and distinctive facial features.",
    "llama-2-7b-chat-hf_fact_raw": "1. Weaver syndrome and Sotos syndrome are both genetic disorders that affect brain development.\n2. Weaver syndrome is characterized by intellectual disability, seizures, and distinctive facial features.\n3. Sotos syndrome is characterized by intellectual disability, growth delays, and distinctive facial features.",
    "llama-2-7b-chat-hf_fact": [
      "Weaver syndrome and Sotos syndrome are both genetic disorders that affect brain development.",
      "Weaver syndrome is characterized by intellectual disability, seizures, and distinctive facial features.",
      "Sotos syndrome is characterized by intellectual disability, growth delays, and distinctive facial features."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Sotos syndrome is characterized by overgrowth in childhood, intellectual disability, and distinctive facial features. Growth delays are not a characteristic of Sotos syndrome; rather, it is rapid growth during the early years.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "llama-2-7b-chat-hf_response": "1. JASPAR 2002: The first release of the JASPAR database, containing 120 transcription factor binding sites from 10 organisms.\n2. JASPAR 2004: An updated version of the database, featuring 200 new transcription factor binding sites and improved prediction accuracy.\n3. JASPAR 2006: Includes 300 new binding sites and improved methods for predicting transcription factor binding affinity.\n4. JASPAR 2008: Features 400 new binding sites and improved prediction accuracy through the use of machine learning algorithms.\n5. JASPAR 2010: Includes 500 new binding sites and improved methods for predicting transcription factor binding specificity.\n6. JASPAR 2012: An updated version of the database, featuring 600 new binding sites and improved prediction accuracy through the use of advanced machine learning techniques.\n7. JASPAR 2016: The latest release of the database, containing 800 new binding sites and improved methods for predicting transcription factor binding affinity and specificity.",
    "llama-2-7b-chat-hf_fact_raw": "1. JASPAR 2002 was the first release of the JASPAR database with 120 transcription factor binding sites from 10 organisms.\n2. JASPAR 2004 added 200 new transcription factor binding sites to the database.\n3. JASPAR 2006 added 300 new transcription factor binding sites to the database.\n4. JASPAR 2008 added 400 new transcription factor binding sites and introduced the use of machine learning algorithms.\n5. JASPAR 2016, the latest release mentioned, added 800 new binding sites to the database.",
    "llama-2-7b-chat-hf_fact": [
      "JASPAR 2002 was the first release of the JASPAR database with 120 transcription factor binding sites from 10 organisms.",
      "JASPAR 2004 added 200 new transcription factor binding sites to the database.",
      "JASPAR 2006 added 300 new transcription factor binding sites to the database.",
      "JASPAR 2008 added 400 new transcription factor binding sites and introduced the use of machine learning algorithms.",
      "JASPAR 2016, the latest release mentioned, added 800 new binding sites to the database."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: JASPAR 2002 was not the first release of the JASPAR database. The initial release of JASPAR was in 2004.\n2. UNKNOWN: Without additional context, it is uncertain whether JASPAR 2004 specifically added 200 new transcription factor binding sites to the database.\n3. UNKNOWN: Without further information, it is unclear whether JASPAR 2006 added exactly 300 new transcription factor binding sites to the database.\n4. UNKNOWN: Without more data, it is unclear whether the statement regarding JASPAR 2008 adding 400 new transcription factor binding sites and introducing the use of machine learning algorithms is accurate.\n5. FALSE [correction]: JASPAR 2016 is not the latest release mentioned by 2023. JASPAR is updated biennially, and there would have been additional releases since 2016, such as JASPAR 2018 and 2020, and possibly a 2022 release by the knowledge cutoff in 2023. However, it is unclear if the 2016 release added 800 new binding sites without additional details.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "llama-2-7b-chat-hf_response": "The function of the viral KP4 protein is to inhibit the host cell's immune response by blocking the activation of the NF-kB pathway.",
    "llama-2-7b-chat-hf_fact_raw": "1. The viral KP4 protein functions to inhibit the host cell's immune response.\n2. The KP4 protein blocks the activation of the NF-kB pathway.",
    "llama-2-7b-chat-hf_fact": [
      "The viral KP4 protein functions to inhibit the host cell's immune response.",
      "The KP4 protein blocks the activation of the NF-kB pathway."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n\nBoth statements are consistent with scientific understandings of viral KP4 proteins which are known to interfere with host immune responses, and the NF-kB pathway is a key component of the immune signaling mechanisms that can be targeted by such viral proteins. However, without specific research or context that clearly defines the function of a hypothetical \"KP4\" protein, this answer is based on the general behavior of viral proteins akin to the described functions. If \"KP4\" is a specific protein that requires a particular study or evidence not provided here, then the answer could change accordingly.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "llama-2-7b-chat-hf_response": "Yes, DITPA (1,1-diethyl-2-methyl-3-[2-imino-5-pyridyl]propyl)amine is a thyroid hormone analog utilized in experimental and clinical studies.",
    "llama-2-7b-chat-hf_fact_raw": "1. DITPA is a thyroid hormone analog.\n2. DITPA is utilized in experimental and clinical studies.",
    "llama-2-7b-chat-hf_fact": [
      "DITPA is a thyroid hormone analog.",
      "DITPA is utilized in experimental and clinical studies."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "llama-2-7b-chat-hf_response": "COUGER is a tool for identifying genes that are differentially expressed between two or more samples based on their gene expression profiles.",
    "llama-2-7b-chat-hf_fact_raw": "1. COUGER is a tool used for identifying differentially expressed genes.\n2. COUGER operates based on gene expression profiles.\n3. COUGER can be used for comparison between two or more samples.",
    "llama-2-7b-chat-hf_fact": [
      "COUGER is a tool used for identifying differentially expressed genes.",
      "COUGER operates based on gene expression profiles.",
      "COUGER can be used for comparison between two or more samples."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n\nThe context does not provide enough specific information about COUGER, which appears to be an acronym or name for a tool or software. Therefore, the truth of the first statement cannot be verified without additional context or knowledge about COUGER. However, statements 2 and 3 hold true for most tools used to identify differentially expressed genes since they typically operate based on gene expression profiles and are used for comparing two or more samples. If COUGER indeed refers to such a tool, these statements are likely to be accurate.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "llama-2-7b-chat-hf_response": "Yes, there are drugs available for the treatment of Tick-borne Encephalitis.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "llama-2-7b-chat-hf_response": "The genome browser database for DNA shape annotations is \"DNA Shape Browser\" (DSB).",
    "llama-2-7b-chat-hf_fact_raw": "1. \"DNA Shape Browser\" (DSB) is a genome browser database for DNA shape annotations.",
    "llama-2-7b-chat-hf_fact": [
      "\"DNA Shape Browser\" (DSB) is a genome browser database for DNA shape annotations."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "llama-2-7b-chat-hf_response": "22q11.2 deletion syndrome and PTEN hamartoma tumor syndrome.",
    "llama-2-7b-chat-hf_fact_raw": "1. 22q11.2 deletion syndrome is associated with mutations in the EZH2 gene.\n2. PTEN hamartoma tumor syndrome is associated with mutations in the EZH2 gene.",
    "llama-2-7b-chat-hf_fact": [
      "22q11.2 deletion syndrome is associated with mutations in the EZH2 gene.",
      "PTEN hamartoma tumor syndrome is associated with mutations in the EZH2 gene."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: 22q11.2 deletion syndrome is associated with a deletion at the q11.2 band of chromosome 22, not with mutations in the EZH2 gene.\n2. FALSE [correction]: PTEN hamartoma tumor syndrome is associated with mutations in the PTEN gene, not in the EZH2 gene.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false"
    ]
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "llama-2-7b-chat-hf_response": "One example of a human protein that undergoes a dimer-to-tetramer transition is the protein p53.",
    "llama-2-7b-chat-hf_fact_raw": "1. The protein p53 undergoes a dimer-to-tetramer transition.",
    "llama-2-7b-chat-hf_fact": [
      "The protein p53 undergoes a dimer-to-tetramer transition."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "llama-2-7b-chat-hf_response": "Bcl-2 is a protein that has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein.",
    "llama-2-7b-chat-hf_fact_raw": "1. Bcl-2 interacts with the protein phospholamban (PLN).\n2. Bcl-2 is an anti-apoptotic protein.",
    "llama-2-7b-chat-hf_fact": [
      "Bcl-2 interacts with the protein phospholamban (PLN).",
      "Bcl-2 is an anti-apoptotic protein."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "llama-2-7b-chat-hf_response": "Yes, several clinical trials have shown that vitamin D supplementation can reduce the incidence of falls in older people.",
    "llama-2-7b-chat-hf_fact_raw": "1. Vitamin D supplementation has been studied in clinical trials.\n2. Clinical trials have shown a reduction in the incidence of falls in older people due to vitamin D supplementation.",
    "llama-2-7b-chat-hf_fact": [
      "Vitamin D supplementation has been studied in clinical trials.",
      "Clinical trials have shown a reduction in the incidence of falls in older people due to vitamin D supplementation."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE (but with a note that evidence may vary and not all studies may show a uniform result).",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "llama-2-7b-chat-hf_response": "Yes, there is an association between Jarid2 and miR-155 in Th17 cells.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "llama-2-7b-chat-hf_response": "9 genes.",
    "llama-2-7b-chat-hf_fact_raw": "1. The human hoxD cluster contains 9 genes.",
    "llama-2-7b-chat-hf_fact": [
      "The human hoxD cluster contains 9 genes."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The human HOXD cluster contains 9-11 genes, depending on the source. The commonly accepted number is 9, but variations exist due to the identification of pseudogenes and gene fragments.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "llama-2-7b-chat-hf_response": "The phosphorylation consensus motifs for Casein Kinase 1 (CK1) are:\n* Ser/Thr-Pro-Thr-Ser/Thr-Pro",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "llama-2-7b-chat-hf_response": "The ASPH gene encodes several isoforms of the aspartate beta-hydroxylase enzyme, including the full-length protein and several truncated forms.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "llama-2-7b-chat-hf_response": "2014",
    "llama-2-7b-chat-hf_fact_raw": "1. Empagliflozin was FDA approved in 2014.",
    "llama-2-7b-chat-hf_fact": [
      "Empagliflozin was FDA approved in 2014."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "llama-2-7b-chat-hf_response": "Loss of the protein Lon1 in the plant Arabidopsis results in increased sensitivity to oxidative stress and reduced plant growth.",
    "llama-2-7b-chat-hf_fact_raw": "1. Loss of protein Lon1 in Arabidopsis leads to increased sensitivity to oxidative stress.\n2. Reduced plant growth is a result of losing protein Lon1 in Arabidopsis.",
    "llama-2-7b-chat-hf_fact": [
      "Loss of protein Lon1 in Arabidopsis leads to increased sensitivity to oxidative stress.",
      "Reduced plant growth is a result of losing protein Lon1 in Arabidopsis."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "llama-2-7b-chat-hf_response": "Yes, a linker histone exists in the yeast genome.",
    "llama-2-7b-chat-hf_fact_raw": "1. A linker histone exists in the yeast genome.",
    "llama-2-7b-chat-hf_fact": [
      "A linker histone exists in the yeast genome."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Yeast, specifically Saccharomyces cerevisiae, does not have linker histones. Yeast chromatin is organized differently compared to that of higher eukaryotes, which do have linker histones.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "llama-2-7b-chat-hf_response": "Yes, there is evidence that tomato juice lowers cholesterol levels by reducing the amount of low-density lipoprotein (LDL) cholesterol in the blood.",
    "llama-2-7b-chat-hf_fact_raw": "1. Tomato juice has been shown to lower cholesterol levels.\n2. Tomato juice reduces the amount of low-density lipoprotein (LDL) cholesterol in the blood.",
    "llama-2-7b-chat-hf_fact": [
      "Tomato juice has been shown to lower cholesterol levels.",
      "Tomato juice reduces the amount of low-density lipoprotein (LDL) cholesterol in the blood."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN: While some studies may suggest that tomato juice has health benefits, such as containing antioxidants that could have an impact on cholesterol levels, the specific effect of tomato juice on lowering overall cholesterol levels cannot be confirmed as universally true without referring to particular scientific studies.\n\n2. UNKNOWN: Similar to statement 1, the specific effect of tomato juice on reducing the amount of low-density lipoprotein (LDL) cholesterol would require evidence from scientific studies to confirm its truthfulness. Without such evidence, the statement remains unverified.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "llama-2-7b-chat-hf_response": "Hsp70 and Hsp110 both promote mRNA stability by binding to the 3' UTR of target mRNAs and preventing their degradation by the 5' to 3' exonuclease activity of the ribosome.",
    "llama-2-7b-chat-hf_fact_raw": "1. Hsp70 and Hsp110 promote mRNA stability.\n2. They bind to the 3' UTR of target mRNAs.\n3. Their binding prevents degradation by the 5' to 3' exonuclease activity of the ribosome.",
    "llama-2-7b-chat-hf_fact": [
      "Hsp70 and Hsp110 promote mRNA stability.",
      "They bind to the 3' UTR of target mRNAs.",
      "Their binding prevents degradation by the 5' to 3' exonuclease activity of the ribosome."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Hsp70 and Hsp110 are molecular chaperones, they do not specifically promote mRNA stability but rather assist in the folding and unfolding of proteins.\n2. UNKNOWN: Without specific context, it's unclear whether Hsp70 and Hsp110 bind to the 3' UTR (untranslated region) of mRNAs as their main function is related to protein folding.\n3. FALSE [correction]: The 5' to 3' exonuclease activity usually refers to RNA degradation by enzymes like XRN1, not the ribosome. Ribosomes are responsible for translating mRNA into protein, not degrading mRNA. Hsp70 and Hsp110 have no direct role in protecting against mRNA degradation by exonucleases; their main function is in protein homeostasis.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "llama-2-7b-chat-hf_response": "The deiodinases present in skeletal muscle are type 1 iodothyronine deiodinase (D1) and type 2 iodothyronine deiodinase (D2).",
    "llama-2-7b-chat-hf_fact_raw": "1. Type 1 iodothyronine deiodinase (D1) is present in skeletal muscle.\n2. Type 2 iodothyronine deiodinase (D2) is present in skeletal muscle.",
    "llama-2-7b-chat-hf_fact": [
      "Type 1 iodothyronine deiodinase (D1) is present in skeletal muscle.",
      "Type 2 iodothyronine deiodinase (D2) is present in skeletal muscle."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Type 1 iodothyronine deiodinase (D1) is primarily present in the liver, kidney, thyroid, and pituitary.\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true"
    ]
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "llama-2-7b-chat-hf_response": "Caspase-1, -4, -5, and -12 are inflammatory caspase proteins.",
    "llama-2-7b-chat-hf_fact_raw": "1. Caspase-1 is an inflammatory caspase protein.\n2. Caspase-4 is an inflammatory caspase protein.\n3. Caspase-5 is an inflammatory caspase protein.\n4. Caspase-12 is an inflammatory caspase protein.",
    "llama-2-7b-chat-hf_fact": [
      "Caspase-1 is an inflammatory caspase protein.",
      "Caspase-4 is an inflammatory caspase protein.",
      "Caspase-5 is an inflammatory caspase protein.",
      "Caspase-12 is an inflammatory caspase protein."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Caspase-12 is generally classified as a non-inflammatory caspase and is involved in the modulation of inflammation and innate immunity, but it does not typically play a direct role in inflammation like caspase-1, -4, and -5.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "llama-2-7b-chat-hf_response": "Yes, there is a link between the aurora B kinase and the polycomb protein Ring1B.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "llama-2-7b-chat-hf_response": "The most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are GU-rich and AG-rich motifs, respectively.",
    "llama-2-7b-chat-hf_fact_raw": "1. The most frequent non-canonical sequence motif at the donor splice site in vertebrates is GU-rich.\n2. The most frequent non-canonical sequence motif at the acceptor splice site in vertebrates is AG-rich.",
    "llama-2-7b-chat-hf_fact": [
      "The most frequent non-canonical sequence motif at the donor splice site in vertebrates is GU-rich.",
      "The most frequent non-canonical sequence motif at the acceptor splice site in vertebrates is AG-rich."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The most frequent canonical sequence motif at the donor splice site in vertebrates is GT-rich (often represented as GT at the intron-exon boundary).\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true"
    ]
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "llama-2-7b-chat-hf_response": "The event that results in the acetylation of S6K1 is the activation of the PI3K/Akt signaling pathway.",
    "llama-2-7b-chat-hf_fact_raw": "1. The acetylation of S6K1 is a result of the activation of the PI3K/Akt signaling pathway.",
    "llama-2-7b-chat-hf_fact": [
      "The acetylation of S6K1 is a result of the activation of the PI3K/Akt signaling pathway."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN\n\nThe statement provided is highly specific and involves complex molecular biology. Without having access to the specific passage or additional context around the statement, it is not possible to accurately verify its truthfulness. Acetylation of proteins such as S6K1 (S6 Kinase 1) can be a result of various signaling pathways and processes within a cell, and the PI3K/Akt pathway is known to be involved in many aspects of cell signaling, including protein synthesis and cellular metabolism. However, without specific reference to a scientific study or source, the relationship between S6K1 acetylation and activation of the PI3K/Akt pathway cannot be confirmed or denied here.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "llama-2-7b-chat-hf_response": "The cause of episodic ataxia type 6 is a mutation in the CACNA1A gene.",
    "llama-2-7b-chat-hf_fact_raw": "1. Episodic ataxia type 6 is caused by a mutation in the CACNA1A gene.",
    "llama-2-7b-chat-hf_fact": [
      "Episodic ataxia type 6 is caused by a mutation in the CACNA1A gene."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "llama-2-7b-chat-hf_response": "Yes, chromomethylases are present in animal genomes.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "llama-2-7b-chat-hf_response": "Some packages available in R/Bioconductor for TFBS analysis are:",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "llama-2-7b-chat-hf_response": "There are several ongoing and completed clinical trials investigating the prevention of sarcopenia. Here are a few examples:\n* A randomized controlled trial published in the Journal of the American Medical Directors Association in 2018 found that a combination of resistance training and nutritional interventions improved muscle mass and functional capacity in older adults at risk of sarcopenia.\n* A systematic review and meta-analysis published in the Journal of the American Geriatrics Society in 2019 found that exercise interventions, including resistance training, aerobic exercise, and combination programs, were effective in preventing sarcopenia in older adults.\n* A randomized controlled trial published in the Journal of Gerontology: Medical Sciences in 2019 found that a 12-month exercise program including resistance training and aerobic exercise improved muscle mass and functional capacity in older adults with mild sarcopenia.\n* A randomized controlled trial published in the Journal of the American Geriatrics Society in 2020 found that a combination of resistance training and nutritional interventions improved muscle mass and functional capacity in older adults with sarcopenia.\nPlease note that these are just a few examples of ongoing and completed clinical trials investigating the prevention of sarcopenia, and there may be other trials ongoing or planned that are not listed here. It is recommended to search for clinical trial databases or reputable medical websites to find the most up-to-date information on sarcopenia clinical trials.",
    "llama-2-7b-chat-hf_fact_raw": "1. A randomized controlled trial published in 2018 found that resistance training and nutritional interventions improved muscle mass and functional capacity in older adults at risk of sarcopenia.\n2. A systematic review and meta-analysis in 2019 indicated that exercise interventions are effective in preventing sarcopenia in older adults.\n3. A randomized controlled trial published in the Journal of Gerontology: Medical Sciences in 2019 showed a 12-month exercise program improved muscle mass and functional capacity in older adults with mild sarcopenia.\n4. A randomized controlled trial from 2020 discovered a combination of resistance training and nutritional interventions was effective in older adults with sarcopenia.",
    "llama-2-7b-chat-hf_fact": [
      "A randomized controlled trial published in 2018 found that resistance training and nutritional interventions improved muscle mass and functional capacity in older adults at risk of sarcopenia.",
      "A systematic review and meta-analysis in 2019 indicated that exercise interventions are effective in preventing sarcopenia in older adults.",
      "A randomized controlled trial published in the Journal of Gerontology: Medical Sciences in 2019 showed a 12-month exercise program improved muscle mass and functional capacity in older adults with mild sarcopenia.",
      "A randomized controlled trial from 2020 discovered a combination of resistance training and nutritional interventions was effective in older adults with sarcopenia."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE - The statement is specific and describes findings that are plausible for a randomized controlled trial studying the effects of resistance training and nutritional interventions on sarcopenia.\n2. TRUE - This statement summarizes the general findings of systematic reviews and meta-analyses, which could be the result of pooling data from multiple studies on exercise interventions aimed at preventing sarcopenia in older adults.\n3. TRUE - The statement provides specifics such as the journal name, year of publication, and details of the intervention and its effects, which makes it credible as a true statement.\n4. TRUE - This statement matches the type of findings that could be reported by a randomized controlled trial and is consistent with current understanding of interventions for sarcopenia, thus it is plausible and can be considered true without further specific evidence.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "llama-2-7b-chat-hf_response": "The database of molecular recognition features in membrane proteins is the Membrane Protein Structural Bioinformatics (MPSB) database.",
    "llama-2-7b-chat-hf_fact_raw": "1. The Membrane Protein Structural Bioinformatics (MPSB) database is a database for molecular recognition features in membrane proteins.",
    "llama-2-7b-chat-hf_fact": [
      "The Membrane Protein Structural Bioinformatics (MPSB) database is a database for molecular recognition features in membrane proteins."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n\nWithout additional context or information about the Membrane Protein Structural Bioinformatics (MPSB) database, I cannot verify the accuracy of this statement. A detailed review of resources, such as scientific literature or the official description of the MPSB database, would be necessary to confirm the purpose and content of the MPSB database.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "llama-2-7b-chat-hf_response": "Yes.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "llama-2-7b-chat-hf_response": "TRalpha2 regulates the expression of genes involved in cardiac contractility, such as MYH7, TNNI3, and TNNT2.",
    "llama-2-7b-chat-hf_fact_raw": "1. TRalpha2 regulates the expression of genes involved in cardiac contractility.\n2. TRalpha2 regulates the expression of the MYH7 gene.\n3. TRalpha2 regulates the expression of the TNNI3 gene.\n4. TRalpha2 regulates the expression of the TNNT2 gene.",
    "llama-2-7b-chat-hf_fact": [
      "TRalpha2 regulates the expression of genes involved in cardiac contractility.",
      "TRalpha2 regulates the expression of the MYH7 gene.",
      "TRalpha2 regulates the expression of the TNNI3 gene.",
      "TRalpha2 regulates the expression of the TNNT2 gene."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nThe statements provided are specific and technical in nature, pertaining to the role of the TRalpha2 (thyroid hormone receptor alpha 2) in gene regulation. Without the context of a specific scientific study or credible source that confirms or denies these claims, it's not possible to determine the accuracy of these statements. The expressions of MYH7, TNNI3, and TNNT2 genes, which are related to cardiac contractility, may be regulated by various factors and it requires specific biochemical knowledge or references to confirm their relationship with TRalpha2.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "llama-2-7b-chat-hf_response": "1. IBM Watson for Healthcare: A comprehensive question answering system that uses natural language processing and machine learning to answer clinical and scientific questions.\n2. Google Cloud Healthcare Natural Language Processing: A cloud-based platform that provides pre-trained models for various healthcare-related tasks, including question answering.\n3. Microsoft Azure Healthcare: Offers a range of AI services, including question answering, based on machine learning and natural language processing.\n4. MedWhat: A question answering system specifically designed for medical professionals, it uses a combination of machine learning and natural language processing.\n5. BioMed Informics: A question answering system that uses natural language processing and machine learning to answer biomedical questions.\n6. PubMedQA: A question answering system that uses natural language processing and machine learning to answer questions from the PubMed database.\n7. BioQA: A question answering system that uses natural language processing and machine learning to answer biomedical questions, with a focus on gene function and protein structure.\n8. Biomedical Question Answering System (BQAS): A comprehensive question answering system that uses natural language processing and machine learning to answer a wide range of biomedical questions.\n9. Biomedical Text Mining and Question Answering System (BTMAQA): A system that uses natural language processing and machine learning to mine biomedical text and answer questions.\n10. Biomedical Knowledge Graph Embedding and Question Answering System (BKGEQA): A system that uses knowledge graph embedding and natural language processing to answer biomedical questions.\nThese systems can be used for various applications, such as clinical decision support, drug discovery, and biomedical research.",
    "llama-2-7b-chat-hf_fact_raw": "1. IBM Watson for Healthcare uses natural language processing and machine learning to answer clinical and scientific questions.\n2. Google Cloud Healthcare Natural Language Processing is a cloud-based platform with pre-trained models for healthcare-related question answering.\n3. Microsoft Azure Healthcare offers AI services including question answering, based on machine learning and natural language processing.\n4. MedWhat is designed for medical professionals, using machine learning and natural language processing.\n5. PubMedQA answers questions from the PubMed database using natural language processing and machine learning.",
    "llama-2-7b-chat-hf_fact": [
      "IBM Watson for Healthcare uses natural language processing and machine learning to answer clinical and scientific questions.",
      "Google Cloud Healthcare Natural Language Processing is a cloud-based platform with pre-trained models for healthcare-related question answering.",
      "Microsoft Azure Healthcare offers AI services including question answering, based on machine learning and natural language processing.",
      "MedWhat is designed for medical professionals, using machine learning and natural language processing.",
      "PubMedQA answers questions from the PubMed database using natural language processing and machine learning."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN\n\nNote: While the fifth statement is likely true as PubMedQA is a question-answering system for biomedical texts and would logically use natural language processing and machine learning, without more context about this specific system or platform, I can't confirm it with certainty.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "llama-2-7b-chat-hf_response": "Î²-glucoronidase",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "llama-2-7b-chat-hf_response": "The preferred technologies for the enrichment of phosphorylated peptides in global quantitative phosphoproteomic analyses are:\n1. High-performance liquid chromatography (HPLC)\n2. Ion exchange chromatography (IEX)\n3. Reversed-phase HPLC (RP-HPLC)\n4. Hydrophilic interaction liquid chromatography (HILIC)\n5. Metal-affinity chromatography (MAC)",
    "llama-2-7b-chat-hf_fact_raw": "1. High-performance liquid chromatography (HPLC) is a preferred technology for the enrichment of phosphorylated peptides.\n2. Ion exchange chromatography (IEX) is used for the enrichment of phosphorylated peptides in phosphoproteomic analyses.\n3. Reversed-phase HPLC (RP-HPLC) is a technology utilized for phosphorylated peptide enrichment.\n4. Hydrophilic interaction liquid chromatography (HILIC) is among the preferred technologies for phosphorylated peptide enrichment.\n5. Metal-affinity chromatography (MAC) is used for the enrichment of phosphorylated peptides in global quantitative phosphoproteomic analyses.",
    "llama-2-7b-chat-hf_fact": [
      "High-performance liquid chromatography (HPLC) is a preferred technology for the enrichment of phosphorylated peptides.",
      "Ion exchange chromatography (IEX) is used for the enrichment of phosphorylated peptides in phosphoproteomic analyses.",
      "Reversed-phase HPLC (RP-HPLC) is a technology utilized for phosphorylated peptide enrichment.",
      "Hydrophilic interaction liquid chromatography (HILIC) is among the preferred technologies for phosphorylated peptide enrichment.",
      "Metal-affinity chromatography (MAC) is used for the enrichment of phosphorylated peptides in global quantitative phosphoproteomic analyses."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: High-performance liquid chromatography (HPLC) is not specifically used for the enrichment of phosphorylated peptides, as it is a more general technique used for separating mixtures of compounds.\n2. FALSE [correction]: Ion exchange chromatography (IEX) is generally not used for the enrichment of phosphorylated peptides. It is used for the separation of molecules based on charge, but it is not the preferred method for this specific task.\n3. FALSE [correction]: Reversed-phase HPLC (RP-HPLC) by itself is not typically used for the enrichment of phosphorylated peptides, as it separates molecules based primarily on hydrophobicity rather than phosphate groups. \n4. TRUE: Hydrophilic interaction liquid chromatography (HILIC) is used for phosphorylated peptide enrichment due to its capability to separate peptides based on their polarity, which is useful for targeting phosphorylated species.\n5. TRUE: Metal-affinity chromatography (MAC), such as immobilized metal affinity chromatography (IMAC), is widely used for the enrichment of phosphorylated peptides in global quantitative phosphoproteomic analyses because the phosphate groups can chelate metal ions, facilitating enrichment.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "llama-2-7b-chat-hf_response": "The Palmini classification is used to rate the severity of chronic obstructive pulmonary disease (COPD).",
    "llama-2-7b-chat-hf_fact_raw": "1. The Palmini classification is used to rate the severity of chronic obstructive pulmonary disease (COPD).",
    "llama-2-7b-chat-hf_fact": [
      "The Palmini classification is used to rate the severity of chronic obstructive pulmonary disease (COPD)."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The GOLD (Global Initiative for Chronic Obstructive Lung Disease) classification is used to rate the severity of chronic obstructive pulmonary disease (COPD), not Palmini classification. The Palmini classification is associated with the classification of hippocampal sclerosis in temporal lobe epilepsy.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "llama-2-7b-chat-hf_response": "Yes, some viruses, such as Epstein-Barr virus (EBV), have been implicated in the etiology of human subacute thyroiditis.",
    "llama-2-7b-chat-hf_fact_raw": "1. Epstein-Barr virus (EBV) has been implicated in the etiology of human subacute thyroiditis.",
    "llama-2-7b-chat-hf_fact": [
      "Epstein-Barr virus (EBV) has been implicated in the etiology of human subacute thyroiditis."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Epstein-Barr virus (EBV) is not traditionally implicated in the etiology of human subacute thyroiditis. Instead, EBV is known to be the cause of infectious mononucleosis and has been associated with various types of cancer, such as Burkitt's lymphoma and nasopharyngeal carcinoma. Subacute thyroiditis, also known as De Quervain's thyroiditis, is often thought to be related to viral infections, but EBV is not commonly cited as a cause.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "llama-2-7b-chat-hf_response": "Yes.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "llama-2-7b-chat-hf_response": "Theatre is a software tool used for genomic analysis, particularly for the analysis of gene expression data. It can be used to visualize and interpret gene expression data, identify differentially expressed genes, and perform functional enrichment analysis. Theatre can also be used to create interactive visualizations and to share results with collaborators or in presentations.",
    "llama-2-7b-chat-hf_fact_raw": "1. Theatre is a software tool used for genomic analysis.\n2. Theatre can analyze gene expression data.\n3. The software can identify differentially expressed genes.\n4. Theatre offers functional enrichment analysis capabilities.\n5. Users can create interactive visualizations with Theatre.",
    "llama-2-7b-chat-hf_fact": [
      "Theatre is a software tool used for genomic analysis.",
      "Theatre can analyze gene expression data.",
      "The software can identify differentially expressed genes.",
      "Theatre offers functional enrichment analysis capabilities.",
      "Users can create interactive visualizations with Theatre."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout additional context or information about the software named \"Theatre,\" it is not possible to accurately verify these statements. The name \"Theatre\" does not correspond to any well-known genomic analysis tools as of my last knowledge update; it may be a hypothetical tool, a new tool that emerged after my last update, or possibly even a misspelling or misrepresentation of an actual tool's name. Therefore, I cannot provide corrections or confirmations for these statements. If \"Theatre\" is a fictional or hypothetical tool created for the purposes of this question, there is no factual basis upon which to evaluate the statements. If it is a real but obscure or new tool, then accurate information would need to be provided or researched based on data provided after my last update.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "llama-2-7b-chat-hf_response": "The execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences is O(n^2), where n is the length of the sequences being aligned. This is because the algorithm compares each element of one sequence to every element of the other sequence, resulting in a quadratic increase in the number of comparisons as the length of the sequences increases.",
    "llama-2-7b-chat-hf_fact_raw": "1. The execution time (complexity) of the Smith-Waterman algorithm is O(n^2).\n2. The complexity O(n^2) is due to the algorithm comparing each element of one sequence to every element of the other sequence.\n3. The number of comparisons increases quadratically as the length of the sequences increases.",
    "llama-2-7b-chat-hf_fact": [
      "The execution time (complexity) of the Smith-Waterman algorithm is O(n^2).",
      "The complexity O(n^2) is due to the algorithm comparing each element of one sequence to every element of the other sequence.",
      "The number of comparisons increases quadratically as the length of the sequences increases."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "llama-2-7b-chat-hf_response": "FLVCR1 is a member of the solute carrier (SLC) family.",
    "llama-2-7b-chat-hf_fact_raw": "1. FLVCR1 is a member of the solute carrier (SLC) family.",
    "llama-2-7b-chat-hf_fact": [
      "FLVCR1 is a member of the solute carrier (SLC) family."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: FLVCR1 is not a member of the solute carrier (SLC) family; it is a member of the major facilitator superfamily (MFS).",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "llama-2-7b-chat-hf_response": "GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach include factors such as p300, CBP, and GATA-3.",
    "llama-2-7b-chat-hf_fact_raw": "1. GATA-1 interacts with p300 using the biotinylation tagging approach.\n2. GATA-1 interacts with CBP using the biotinylation tagging approach.\n3. GATA-1 interacts with GATA-3 using the biotinylation tagging approach.",
    "llama-2-7b-chat-hf_fact": [
      "GATA-1 interacts with p300 using the biotinylation tagging approach.",
      "GATA-1 interacts with CBP using the biotinylation tagging approach.",
      "GATA-1 interacts with GATA-3 using the biotinylation tagging approach."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n\nWithout the passage text or specific scientific findings mentioned, it is difficult to determine the truthfulness of the statements concerning protein interactions. The biotinylation tagging approach is a laboratory method that could be used to study protein interactions, but without specific experimental evidence or literature, the interactions of GATA-1 with p300, CBP, or GATA-3 cannot be confirmed or denied.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "llama-2-7b-chat-hf_response": "TAF10 interacting with the GATA1 transcription factor leads to the formation of a stable complex that is required for the regulation of gene expression during erythropoiesis.",
    "llama-2-7b-chat-hf_fact_raw": "1. TAF10 interaction with GATA1 transcription factor forms a stable complex.\n2. The complex formed is required for the regulation of gene expression.\n3. This regulation of gene expression is necessary during erythropoiesis.",
    "llama-2-7b-chat-hf_fact": [
      "TAF10 interaction with GATA1 transcription factor forms a stable complex.",
      "The complex formed is required for the regulation of gene expression.",
      "This regulation of gene expression is necessary during erythropoiesis."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n\nGiven the specificity of the statements, they are likely derived from a passage discussing transcription factors' roles in erythropoiesis. In molecular biology, complexes between transcription factors, like GATA1, and TAFs (TATA-box Binding Protein Associated Factors) indeed play critical roles in the regulation of gene expression which is vital during processes such as erythropoiesis, the production of red blood cells. Without additional context that contradicts these specific claims, these statements are assumed to be true.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "llama-2-7b-chat-hf_response": "Yes, there are several decision support systems (DSS) available for chronic pain management. These systems use various algorithms and models to analyze patient-specific data and provide personalized recommendations for pain management. Some examples of DSS for chronic pain management include the Chronic Pain Management Decision Support System (CPMDSS), the Pain Management Decision Support System (PMDSS), and the Multimodal Pain Management Decision Support System (MPMDSS). These systems can help healthcare providers make more informed decisions regarding treatment options and improve patient outcomes.",
    "llama-2-7b-chat-hf_fact_raw": "1. Decision support systems (DSS) are available for chronic pain management.\n2. Chronic Pain Management Decision Support System (CPMDSS) is an example of a DSS for chronic pain management.\n3. Pain Management Decision Support System (PMDSS) is an example of a DSS for chronic pain management.\n4. Multimodal Pain Management Decision Support System (MPMDSS) is an example of a DSS for chronic pain management.\n5. These DSS use algorithms and models to analyze patient-specific data for pain management recommendations.",
    "llama-2-7b-chat-hf_fact": [
      "Decision support systems (DSS) are available for chronic pain management.",
      "Chronic Pain Management Decision Support System (CPMDSS) is an example of a DSS for chronic pain management.",
      "Pain Management Decision Support System (PMDSS) is an example of a DSS for chronic pain management.",
      "Multimodal Pain Management Decision Support System (MPMDSS) is an example of a DSS for chronic pain management.",
      "These DSS use algorithms and models to analyze patient-specific data for pain management recommendations."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE\n\nThe names of specific decision support systems like Chronic Pain Management Decision Support System (CPMDSS), Pain Management Decision Support System (PMDSS), and Multimodal Pain Management Decision Support System (MPMDSS) cannot be verified without additional context. However, the statement that decision support systems use algorithms and models to analyze patient-specific data for recommendations is a fundamental characteristic of DSS, particularly in the context of medical applications such as pain management.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "llama-2-7b-chat-hf_response": "Angiogenin is a protein that is localized in the cytoplasm of cells.",
    "llama-2-7b-chat-hf_fact_raw": "1. Angiogenin is a protein.\n2. Angiogenin is localized in the cytoplasm of cells.",
    "llama-2-7b-chat-hf_fact": [
      "Angiogenin is a protein.",
      "Angiogenin is localized in the cytoplasm of cells."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "llama-2-7b-chat-hf_response": "Ranolazine inhibits the activation of kinase signaling in the heart by blocking the activity of the enzyme, protein kinase C.",
    "llama-2-7b-chat-hf_fact_raw": "1. Ranolazine inhibits the activation of kinase signaling in the heart.\n2. Ranolazine blocks the activity of the enzyme called protein kinase C.",
    "llama-2-7b-chat-hf_fact": [
      "Ranolazine inhibits the activation of kinase signaling in the heart.",
      "Ranolazine blocks the activity of the enzyme called protein kinase C."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Ranolazine is primarily known to inhibit the late sodium current in the heart, not the activation of kinase signaling.\n2. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown"
    ]
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "llama-2-7b-chat-hf_response": "Yes, the regulation of Vsr endonuclease is independent of the growth phase of bacteria. Vsr endonuclease is regulated by a complex interplay of transcriptional and post-transcriptional factors, including the RNA-binding protein Hfq, and is not directly linked to the growth phase of bacteria.",
    "llama-2-7b-chat-hf_fact_raw": "1. The regulation of Vsr endonuclease is independent of the growth phase of bacteria.\n2. The regulation of Vsr endonuclease involves both transcriptional and post-transcriptional factors.\n3. The RNA-binding protein Hfq is involved in the regulation of Vsr endonuclease.",
    "llama-2-7b-chat-hf_fact": [
      "The regulation of Vsr endonuclease is independent of the growth phase of bacteria.",
      "The regulation of Vsr endonuclease involves both transcriptional and post-transcriptional factors.",
      "The RNA-binding protein Hfq is involved in the regulation of Vsr endonuclease."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n\nExplanation: The statements pertain to specific biochemical regulatory processes involving Vsr endonuclease which could potentially involve growth-phase dependence and various regulatory factors, including transcriptional and post-transcriptional mechanisms, as well as the possible involvement of RNA-binding proteins like Hfq. However, without the specific context or scientific data presented in the provided text, I cannot accurately determine the truthfulness of these statements. Insights into such molecular processes typically require detailed knowledge from specific scientific studies or literature, which isn't provided in this scenario.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "llama-2-7b-chat-hf_response": "TMHMM, TMFAM, and PredictProtein",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "llama-2-7b-chat-hf_response": "Galassi classification is used for spinal muscular atrophy.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "llama-2-7b-chat-hf_response": "- Progressive muscle weakness\n- Muscle wasting\n- Loss of motor skills\n- Difficulty with speech and swallowing\n- Vision problems\n- Cognitive decline\n- Sleep disturbances\n- Respiratory problems\n- Increased risk of infections\n- Short stature\n- Distinctive facial features",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "llama-2-7b-chat-hf_response": "BRAG1 is linked to Charcot-Marie-Tooth disease.",
    "llama-2-7b-chat-hf_fact_raw": "1. Charcot-Marie-Tooth disease is linked to mutations within BRAG1.",
    "llama-2-7b-chat-hf_fact": [
      "Charcot-Marie-Tooth disease is linked to mutations within BRAG1."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Charcot-Marie-Tooth disease is linked to mutations in a number of genes, but BRAG1 is not commonly associated with this disease. Mutations in genes such as PMP22, GJB1, MFN2, MPZ, and others are known to be involved in the development of Charcot-Marie-Tooth disease.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 1362,
    "user_query": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "llama-2-7b-chat-hf_response": "Calcium/calmodulin-dependent protein kinase II (CaMKII)",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "llama-2-7b-chat-hf_response": "DNA damage response and repair pathways.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "llama-2-7b-chat-hf_response": "Erythromelalgia is a rare genetic disorder that affects the blood vessels and causes excessive heat production in the hands and feet. The exact cause of erythromelalgia is not fully understood, but it is believed to be related to mutations in genes that regulate the function of ion channels in the skin.",
    "llama-2-7b-chat-hf_fact_raw": "1. Erythromelalgia affects the blood vessels and causes excessive heat production in the hands and feet.\n2. The exact cause of erythromelalgia is not fully understood.\n3. It is believed that erythromelalgia is related to mutations in genes that regulate the function of ion channels in the skin.",
    "llama-2-7b-chat-hf_fact": [
      "Erythromelalgia affects the blood vessels and causes excessive heat production in the hands and feet.",
      "The exact cause of erythromelalgia is not fully understood.",
      "It is believed that erythromelalgia is related to mutations in genes that regulate the function of ion channels in the skin."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "llama-2-7b-chat-hf_response": "Hydrochlorothiazide is used to treat hypertension (high blood pressure), heart failure, and edema (fluid retention).",
    "llama-2-7b-chat-hf_fact_raw": "1. Hydrochlorothiazide is used to treat hypertension.\n2. Hydrochlorothiazide is used for the treatment of heart failure.\n3. Hydrochlorothiazide is used to manage edema (fluid retention).",
    "llama-2-7b-chat-hf_fact": [
      "Hydrochlorothiazide is used to treat hypertension.",
      "Hydrochlorothiazide is used for the treatment of heart failure.",
      "Hydrochlorothiazide is used to manage edema (fluid retention)."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "llama-2-7b-chat-hf_response": "Yes, silicon has been used in the treatment of urinary incontinence.",
    "llama-2-7b-chat-hf_fact_raw": "1. Silicon has been used in the treatment of urinary incontinence.",
    "llama-2-7b-chat-hf_fact": [
      "Silicon has been used in the treatment of urinary incontinence."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Silicone has been used in the treatment of urinary incontinence, not silicon. Silicon is a chemical element, while silicone is a synthetic material made from silicon and other elements like carbon, hydrogen, and oxygen.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "llama-2-7b-chat-hf_response": "There is a significant association between the moon cycle and the risk of rupture of intracranial aneurysms.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "llama-2-7b-chat-hf_response": "Yes, HuR protein is known to regulate the splicing process by binding to specific splicing regulatory elements and modulating the splicing machinery.",
    "llama-2-7b-chat-hf_fact_raw": "1. HuR protein is known to regulate the splicing process.\n2. HuR protein binds to specific splicing regulatory elements.\n3. HuR protein modulates the splicing machinery.",
    "llama-2-7b-chat-hf_fact": [
      "HuR protein is known to regulate the splicing process.",
      "HuR protein binds to specific splicing regulatory elements.",
      "HuR protein modulates the splicing machinery."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: HuR protein is primarily known for its role in stabilizing and regulating the turnover of mRNAs by binding to AU-rich elements in their 3' untranslated regions (UTRs), not for regulating the splicing process.\n2. TRUE: While HuR is mostly noted for its role in binding to AU-rich elements in regulating mRNA stability, it can also interact with splicing regulatory elements, though this is not its primary function.\n3. UNKNOWN: The specific role of HuR protein in modulating the splicing machinery is not well-defined, and it is more generally known for its role in mRNA stability and regulation. Some studies do suggest a potential role in splicing, but it is not conclusively established as a main function.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "llama-2-7b-chat-hf_response": "Prothymosin alpha c-terminal peptide has been shown to have anti-inflammatory and anti-apoptotic effects, and may play a role in the regulation of cell proliferation and differentiation.",
    "llama-2-7b-chat-hf_fact_raw": "1. Prothymosin alpha c-terminal peptide has anti-inflammatory effects.\n2. Prothymosin alpha c-terminal peptide has anti-apoptotic effects.\n3. Prothymosin alpha c-terminal peptide may play a role in the regulation of cell proliferation.\n4. Prothymosin alpha c-terminal peptide may play a role in the regulation of cell differentiation.",
    "llama-2-7b-chat-hf_fact": [
      "Prothymosin alpha c-terminal peptide has anti-inflammatory effects.",
      "Prothymosin alpha c-terminal peptide has anti-apoptotic effects.",
      "Prothymosin alpha c-terminal peptide may play a role in the regulation of cell proliferation.",
      "Prothymosin alpha c-terminal peptide may play a role in the regulation of cell differentiation."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n\nProthymosin alpha (ProTÎ±) is known for its various biological roles, including anti-inflammatory and anti-apoptotic effects. It also plays a role in the regulation of cell proliferation and cell differentiation. The c-terminal peptide of ProTÎ± retains some of these activities. However, these statements would be more accurately verified by reviewing current scientific literature for the latest research findings.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "llama-2-7b-chat-hf_response": "Î²-sheet rich peptide 1 (BRIP1) plays a pivotal role in human cystatin C fibrillization.",
    "llama-2-7b-chat-hf_fact_raw": "1. Î²-sheet rich peptide 1 (BRIP1) plays a pivotal role in human cystatin C fibrillization.",
    "llama-2-7b-chat-hf_fact": [
      "Î²-sheet rich peptide 1 (BRIP1) plays a pivotal role in human cystatin C fibrillization."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n\n[Note: Without specific scientific context or a reliable source citation, it is not possible to confirm the accuracy of the statement regarding Î²-sheet rich peptide 1 (BRIP1) and its role in human cystatin C fibrillization. This would require expertise in biochemistry and access to the relevant scientific literature.]",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1Î± increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "llama-2-7b-chat-hf_response": "Yes.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "llama-2-7b-chat-hf_response": "Set7 deposits histone marks H3K4me3 and H3K27me3.",
    "llama-2-7b-chat-hf_fact_raw": "1. Set7 deposits the histone mark H3K4me3.\n2. Set7 deposits the histone mark H3K27me3.",
    "llama-2-7b-chat-hf_fact": [
      "Set7 deposits the histone mark H3K4me3.",
      "Set7 deposits the histone mark H3K27me3."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Set7 (also known as SETD7) deposits the histone mark H3K4me1, not H3K4me3.\n2. FALSE [correction]: Set7 is not responsible for depositing the histone mark H3K27me3, this is typically attributed to EZH2 as part of the PRC2 complex.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false"
    ]
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "llama-2-7b-chat-hf_response": "12 disulfide bridges.",
    "llama-2-7b-chat-hf_fact_raw": "1. The protein hepcidin has 12 disulfide bridges.",
    "llama-2-7b-chat-hf_fact": [
      "The protein hepcidin has 12 disulfide bridges."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The protein hepcidin typically has 8 disulfide bridges.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "llama-2-7b-chat-hf_response": "The protein encoded by the gene DNAJC11 is localized in the cytoplasm.",
    "llama-2-7b-chat-hf_fact_raw": "1. The protein encoded by DNAJC11 is found in the cytoplasm.",
    "llama-2-7b-chat-hf_fact": [
      "The protein encoded by DNAJC11 is found in the cytoplasm."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n\nThe provided statement about the subcellular location of the protein encoded by the gene DNAJC11 does not contain enough information to determine its veracity without additional context. This information would typically require referencing specific scientific literature or databases that detail such properties of proteins.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "llama-2-7b-chat-hf_response": "Yes, ultraconserved elements are depleted among copy number variants (CNVs).",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "llama-2-7b-chat-hf_response": "The substrate of HASPIN kinase during mitosis is the protein PP2A.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "llama-2-7b-chat-hf_response": "Viroid replication is a unique mechanism of replication that involves the RNA-dependent RNA polymerase enzyme, which synthesizes new RNA molecules from the existing ones, resulting in an exponential increase in the amount of viroid RNA in the infected cell.",
    "llama-2-7b-chat-hf_fact_raw": "1. Viroid replication involves the RNA-dependent RNA polymerase enzyme.\n2. The RNA-dependent RNA polymerase enzyme synthesizes new RNA molecules from existing ones.\n3. Viroid replication results in an exponential increase in the amount of viroid RNA in the infected cell.",
    "llama-2-7b-chat-hf_fact": [
      "Viroid replication involves the RNA-dependent RNA polymerase enzyme.",
      "The RNA-dependent RNA polymerase enzyme synthesizes new RNA molecules from existing ones.",
      "Viroid replication results in an exponential increase in the amount of viroid RNA in the infected cell."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "llama-2-7b-chat-hf_response": "Yes, fibronectin levels have been found to be significantly lower in patients with Duchenne muscular dystrophy compared to healthy controls, making it a potential serum biomarker for the disease.",
    "llama-2-7b-chat-hf_fact_raw": "1. Fibronectin levels are significantly lower in patients with Duchenne muscular dystrophy compared to healthy controls.\n2. Fibronectin is a potential serum biomarker for Duchenne muscular dystrophy.",
    "llama-2-7b-chat-hf_fact": [
      "Fibronectin levels are significantly lower in patients with Duchenne muscular dystrophy compared to healthy controls.",
      "Fibronectin is a potential serum biomarker for Duchenne muscular dystrophy."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n\nFibronectin levels can indeed be different in patients with certain conditions compared to healthy controls, and it can be used as a biomarker for illness, including possibly Duchenne muscular dystrophy. However, without specific data or a source to confirm the contextual details of these statements, the responses are based on general knowledge that fibronectin can be a serum biomarker, and its levels can be significant in various diseases.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "llama-2-7b-chat-hf_response": "The DeepBlue epigenomic data server contains data from several major epigenome projects, including the ENCODE (ENCyclopedia Of DNA Elements) project and the Roadmap Epigenomics Project.",
    "llama-2-7b-chat-hf_fact_raw": "1. The DeepBlue epigenomic data server contains data from the ENCODE project.\n2. The DeepBlue epigenomic data server contains data from the Roadmap Epigenomics Project.",
    "llama-2-7b-chat-hf_fact": [
      "The DeepBlue epigenomic data server contains data from the ENCODE project.",
      "The DeepBlue epigenomic data server contains data from the Roadmap Epigenomics Project."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "llama-2-7b-chat-hf_response": "The tool that employs self-organizing maps for analyzing synonymous codon usage is \"codonscope.\"",
    "llama-2-7b-chat-hf_fact_raw": "1. Codonscope is a tool that uses self-organizing maps.\n2. Codonscope is employed for analyzing synonymous codon usage.",
    "llama-2-7b-chat-hf_fact": [
      "Codonscope is a tool that uses self-organizing maps.",
      "Codonscope is employed for analyzing synonymous codon usage."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true"
    ]
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "llama-2-7b-chat-hf_response": "MINDY-1 is a machine learning model developed by researchers at Stanford University that can predict the likelihood of a patient experiencing a cardiovascular event, such as a heart attack or stroke, based on their electronic health record (EHR) data.",
    "llama-2-7b-chat-hf_fact_raw": "1. MINDY-1 is a machine learning model.\n2. MINDY-1 was developed by researchers at Stanford University.\n3. MINDY-1 predicts the likelihood of a patient experiencing a cardiovascular event.\n4. MINDY-1 uses electronic health record (EHR) data for predictions.",
    "llama-2-7b-chat-hf_fact": [
      "MINDY-1 is a machine learning model.",
      "MINDY-1 was developed by researchers at Stanford University.",
      "MINDY-1 predicts the likelihood of a patient experiencing a cardiovascular event.",
      "MINDY-1 uses electronic health record (EHR) data for predictions."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nWithout specific information regarding the existence and attributes of a machine learning model named \"MINDY-1,\" it is not possible to verify these statements. They could be part of a hypothetical scenario, a non-public research project, or simply fictional.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "llama-2-7b-chat-hf_response": "The software package available for the analysis of conserved genomic loci is called \"Conservation Score\".",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "llama-2-7b-chat-hf_response": "1. Epidermolysis bullosa acquisita: A skin fragility disorder characterized by blistering and scarring following minor trauma.\n2. Dystrophic epidermolysis bullosa: A severe form of epidermolysis bullosa characterized by widespread blistering and scarring, particularly on the skin and mucous membranes.\n3. Keratitis ichthyosis deafness syndrome: A rare genetic disorder characterized by dry, scaly skin, hearing loss, and eye problems.",
    "llama-2-7b-chat-hf_fact_raw": "1. Epidermolysis bullosa acquisita is associated with the PIEZO2 gene and is characterized by blistering and scarring following minor trauma.\n2. Dystrophic epidermolysis bullosa, a form of epidermolysis bullosa associated with the PIEZO2 gene, is characterized by widespread blistering and scarring.\n3. Keratitis ichthyosis deafness syndrome, a rare genetic disorder associated with the PIEZO2 gene, is characterized by dry, scaly skin, hearing loss, and eye problems.",
    "llama-2-7b-chat-hf_fact": [
      "Epidermolysis bullosa acquisita is associated with the PIEZO2 gene and is characterized by blistering and scarring following minor trauma.",
      "Dystrophic epidermolysis bullosa, a form of epidermolysis bullosa associated with the PIEZO2 gene, is characterized by widespread blistering and scarring.",
      "Keratitis ichthyosis deafness syndrome, a rare genetic disorder associated with the PIEZO2 gene, is characterized by dry, scaly skin, hearing loss, and eye problems."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Epidermolysis bullosa acquisita is not associated with the PIEZO2 gene. It is a rare autoimmune blistering disorder and is characterized by blistering and scarring following minor trauma. The PIEZO2 gene has been implicated in mechanosensation, not in epidermolysis bullosa.\n2. UNKNOWN: Dystrophic epidermolysis bullosa is indeed a form of epidermolysis bullosa characterized by widespread blistering and scarring, but typically it is associated with mutations in the COL7A1 gene, which encodes type VII collagen. There is no direct established association with the PIEZO2 gene mentioned in standard literature for dystrophic epidermolysis bullosa.\n3. FALSE [correction]: Keratitis ichthyosis deafness (KID) syndrome is associated with mutations in the GJB2 gene encoding connexin 26, not the PIEZO2 gene. It is characterized by dry, scaly skin, hearing loss, and eye problems.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "llama-2-7b-chat-hf_response": "ERAP1-ERAP2 dimerization promotes the degradation of misfolded proteins.",
    "llama-2-7b-chat-hf_fact_raw": "1. ERAP1-ERAP2 dimerization promotes the degradation of misfolded proteins.",
    "llama-2-7b-chat-hf_fact": [
      "ERAP1-ERAP2 dimerization promotes the degradation of misfolded proteins."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN\n\nThe statement provided relates to a specific scientific mechanism involving the proteins ERAP1 and ERAP2. Without additional context or a specific reference, it is difficult to verify the accuracy of this statement. ERAP1 and ERAP2 are indeed involved in protein processing, such as trimming peptides for presentation by MHC class I molecules, but without further context or reference to a credible scientific source, it is not possible to confirm whether the statement regarding their role in the degradation of misfolded proteins through dimerization is true or false.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "llama-2-7b-chat-hf_response": "R-spondin 1 and Noggin are involved in the regulation of bile acid synthesis and gallbladder function. In non-damaged gallbladders, R-spondin 1 and Noggin promote the differentiation and proliferation of cholangiocytes, the cells that line the bile ducts.",
    "llama-2-7b-chat-hf_fact_raw": "1. R-spondin 1 and Noggin regulate bile acid synthesis.\n2. R-spondin 1 and Noggin are involved in gallbladder function.\n3. R-spondin 1 and Noggin promote the differentiation and proliferation of cholangiocytes in non-damaged gallbladders.",
    "llama-2-7b-chat-hf_fact": [
      "R-spondin 1 and Noggin regulate bile acid synthesis.",
      "R-spondin 1 and Noggin are involved in gallbladder function.",
      "R-spondin 1 and Noggin promote the differentiation and proliferation of cholangiocytes in non-damaged gallbladders."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: R-spondin 1 and Noggin do not regulate bile acid synthesis; they are involved in regulating various aspects of cellular growth and differentiation, particularly in the context of development and tissue regeneration.\n2. UNKNOWN: Without specific context or research data, it is difficult to determine the involvement of R-spondin 1 and Noggin in gallbladder function, as these proteins have broader roles in development and tissue repair.\n3. UNKNOWN: The statement about R-spondin 1 and Noggin promoting the differentiation and proliferation of cholangiocytes (cells that line the bile ducts) in non-damaged gallbladders is specific and would require access to relevant scientific research to confirm or deny. Without that, the truthfulness of this statement cannot be determined.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "llama-2-7b-chat-hf_response": "Yes, NADPH oxidase 5 requires the subunit POR1 for function.",
    "llama-2-7b-chat-hf_fact_raw": "1. NADPH oxidase 5 requires a subunit to function.\n2. The subunit required for NADPH oxidase 5 function is POR1.",
    "llama-2-7b-chat-hf_fact": [
      "NADPH oxidase 5 requires a subunit to function.",
      "The subunit required for NADPH oxidase 5 function is POR1."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: The term \"POR1\" is not a standard subunit or component recognized in the context of NADPH oxidases. Subunits associated with the NADPH oxidase family typically include p22phox, p40phox, p47phox, p67phox, and gp91phox/Nox2, among others. NADPH oxidase 5 (Nox5) is unique because it does not require p22phox or any of the other subunits for its activity; it is generally considered to be a standalone enzyme.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false"
    ]
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "llama-2-7b-chat-hf_response": "Furin and hepcidin are both involved in the regulation of iron metabolism. Furin is a protease that processes hepcidin, a hormone that regulates iron absorption and release from storage sites in the body.",
    "llama-2-7b-chat-hf_fact_raw": "1. Furin is a protease.\n2. Hepcidin is a hormone.\n3. Furin processes hepcidin.\n4. Hepcidin regulates iron absorption and release from storage sites in the body.",
    "llama-2-7b-chat-hf_fact": [
      "Furin is a protease.",
      "Hepcidin is a hormone.",
      "Furin processes hepcidin.",
      "Hepcidin regulates iron absorption and release from storage sites in the body."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Furin is known for processing precursor proteins into their biologically active forms, but hepcidin is synthesized mainly in the liver and its maturation is not typically associated with furin.\n4. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "llama-2-7b-chat-hf_response": "The largest metabolic gene cluster in yeast is the glycolysis pathway.",
    "llama-2-7b-chat-hf_fact_raw": "1. The glycolysis pathway is the largest metabolic gene cluster in yeast.",
    "llama-2-7b-chat-hf_fact": [
      "The glycolysis pathway is the largest metabolic gene cluster in yeast."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The glycolysis pathway is not the largest metabolic gene cluster in yeast. It is a central metabolic pathway that consists of a series of enzymatic reactions that break down glucose into pyruvate, but it does not represent the largest gene cluster. The largest metabolic gene clusters in yeast, such as those for ribosome production, involve a greater number of genes.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "llama-2-7b-chat-hf_response": "The role of LIMT lncRNA is to regulate the expression of nearby genes by blocking the recruitment of RNA polymerase II.",
    "llama-2-7b-chat-hf_fact_raw": "1. LIMT lncRNA regulates the expression of nearby genes.\n2. LIMT lncRNA blocks the recruitment of RNA polymerase II.",
    "llama-2-7b-chat-hf_fact": [
      "LIMT lncRNA regulates the expression of nearby genes.",
      "LIMT lncRNA blocks the recruitment of RNA polymerase II."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n\nThe statements provided are subject-specific assertions that can be true or false based on recent scientific findings, and without the proper context or the latest research data, it is not possible to confirm their accuracy. Long non-coding RNAs (lncRNAs) like LIMT may have various roles in gene regulation, but whether LIMT specifically regulates the expression of nearby genes or blocks the recruitment of RNA polymerase II can only be confirmed by referring to the relevant scientific literature.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "llama-2-7b-chat-hf_response": "One R/Bioconductor package used for performing SNP enrichment analysis is \"SNPtest.\"",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "llama-2-7b-chat-hf_response": "The key players in radial glial specification to ependymal cells include the Notch signaling pathway, the Wnt/Î²-catenin pathway, and the Shh signaling pathway.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "llama-2-7b-chat-hf_response": "Triple negative gliomas are characterized by the absence of tumor cells that express cytokeratin, EGFR, and MIB1.",
    "llama-2-7b-chat-hf_fact_raw": "1. Triple negative gliomas do not express cytokeratin in tumor cells.\n2. Triple negative gliomas do not express EGFR in tumor cells.\n3. Triple negative gliomas do not express MIB1 in tumor cells.",
    "llama-2-7b-chat-hf_fact": [
      "Triple negative gliomas do not express cytokeratin in tumor cells.",
      "Triple negative gliomas do not express EGFR in tumor cells.",
      "Triple negative gliomas do not express MIB1 in tumor cells."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: Triple negative gliomas do not typically express markers such as estrogen receptor (ER), progesterone receptor (PR), and HER2/neu, not EGFR which can be expressed in various types of gliomas.\n3. FALSE [correction]: MIB1 is a marker for cell proliferation and can be expressed in tumor cells, including those in gliomas, to indicate the proportion of proliferating cells. Triple negative gliomas lacking specific receptor markers might still express proliferation markers like MIB1.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "llama-2-7b-chat-hf_response": "TOPAZ1 is a gene that has been associated with the development of certain types of cancer, including breast cancer.",
    "llama-2-7b-chat-hf_fact_raw": "1. TOPAZ1 is a gene.\n2. TOPAZ1 has been linked with the development of some cancers.\n3. TOPAZ1 is associated with breast cancer.",
    "llama-2-7b-chat-hf_fact": [
      "TOPAZ1 is a gene.",
      "TOPAZ1 has been linked with the development of some cancers.",
      "TOPAZ1 is associated with breast cancer."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n\nWithout specific and up-to-date scientific information provided on TOPAZ1, the statements about its characteristics and associations with certain cancers cannot be verified as true or false.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "llama-2-7b-chat-hf_response": "The gene that controls the expression of GATA-1 isoforms is the GATA-1 gene itself.",
    "llama-2-7b-chat-hf_fact_raw": "1. The GATA-1 gene controls the expression of GATA-1 isoforms.",
    "llama-2-7b-chat-hf_fact": [
      "The GATA-1 gene controls the expression of GATA-1 isoforms."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "llama-2-7b-chat-hf_response": "MIRA-seq is a tool used to identify and characterize long non-coding RNAs (lncRNAs) in the human genome.",
    "llama-2-7b-chat-hf_fact_raw": "1. MIRA-seq is used to identify long non-coding RNAs in the human genome.\n2. MIRA-seq is also used to characterize long non-coding RNAs in the human genome.",
    "llama-2-7b-chat-hf_fact": [
      "MIRA-seq is used to identify long non-coding RNAs in the human genome.",
      "MIRA-seq is also used to characterize long non-coding RNAs in the human genome."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "llama-2-7b-chat-hf_response": "The indication of ARCALYST is for the treatment of acute pain in adults.",
    "llama-2-7b-chat-hf_fact_raw": "1. ARCALYST is indicated for the treatment of acute pain.\n2. ARCALYST is indicated for use in adults.",
    "llama-2-7b-chat-hf_fact": [
      "ARCALYST is indicated for the treatment of acute pain.",
      "ARCALYST is indicated for use in adults."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: ARCALYST (rilonacept) is not indicated for the treatment of acute pain. It is used for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Auto-inflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS), and for the treatment of Deficiency of Interleukin-1 Receptor Antagonist (DIRA), in adults and children.\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true"
    ]
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "llama-2-7b-chat-hf_response": "13, 14, 15, and 21 are the human acrocentric chromosomes involved in Robertsonian translocation.",
    "llama-2-7b-chat-hf_fact_raw": "1. Chromosome 13 is a human acrocentric chromosome involved in Robertsonian translocation.\n2. Chromosome 14 is a human acrocentric chromosome involved in Robertsonian translocation.\n3. Chromosome 15 is a human acrocentric chromosome involved in Robertsonian translocation.\n4. Chromosome 21 is a human acrocentric chromosome involved in Robertsonian translocation.",
    "llama-2-7b-chat-hf_fact": [
      "Chromosome 13 is a human acrocentric chromosome involved in Robertsonian translocation.",
      "Chromosome 14 is a human acrocentric chromosome involved in Robertsonian translocation.",
      "Chromosome 15 is a human acrocentric chromosome involved in Robertsonian translocation.",
      "Chromosome 21 is a human acrocentric chromosome involved in Robertsonian translocation."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "llama-2-7b-chat-hf_response": "One R package that could be used for the identification of pediatric brain tumors is \"brainTumor\".",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "llama-2-7b-chat-hf_response": "Yes.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "llama-2-7b-chat-hf_response": "Yes.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "llama-2-7b-chat-hf_response": "Origins of replication close to yeast centromeres fire early.",
    "llama-2-7b-chat-hf_fact_raw": "1. Origins of replication close to yeast centromeres fire early.",
    "llama-2-7b-chat-hf_fact": [
      "Origins of replication close to yeast centromeres fire early."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "llama-2-7b-chat-hf_response": "Mammalian GA-sequences are short sequences of 3-5 nucleotides that are highly conserved and are found in the 3' untranslated region of mRNAs. They are involved in the regulation of mRNA stability and translation.",
    "llama-2-7b-chat-hf_fact_raw": "1. Mammalian GA-sequences are short sequences of 3-5 nucleotides.\n2. They are highly conserved sequences.\n3. GA-sequences are found in the 3' untranslated region of mRNAs.\n4. Mammalian GA-sequences are involved in the regulation of mRNA stability.\n5. They also play a role in the regulation of mRNA translation.",
    "llama-2-7b-chat-hf_fact": [
      "Mammalian GA-sequences are short sequences of 3-5 nucleotides.",
      "They are highly conserved sequences.",
      "GA-sequences are found in the 3' untranslated region of mRNAs.",
      "Mammalian GA-sequences are involved in the regulation of mRNA stability.",
      "They also play a role in the regulation of mRNA translation."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Mammalian GA-rich sequences are typically longer than 3-5 nucleotides, often around 5-7 nucleotides in length or even longer.\n2. TRUE: GA-rich sequences can be conserved elements, particularly if they play a role in gene regulation.\n3. TRUE: GA-sequences can be found in the 3' untranslated regions (UTRs) of mRNAs where they may participate in post-transcriptional regulation.\n4. TRUE: Mammalian GA-sequences are known to be involved in the regulation of mRNA stability.\n5. TRUE: GA-sequences can also play a role in the regulation of mRNA translation.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2291,
    "user_query": "How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "llama-2-7b-chat-hf_response": "10 GRG genes are contained in the mouse genome.",
    "llama-2-7b-chat-hf_fact_raw": "1. There are 10 GRG genes in the mouse genome.",
    "llama-2-7b-chat-hf_fact": [
      "There are 10 GRG genes in the mouse genome."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN\n\nThe number of GRG (Groucho-related gene) genes in the mouse genome is not specified in the provided context, and without additional information, it is not possible to verify the accuracy of the statement.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "llama-2-7b-chat-hf_response": "RNA polymerase II subunit RPB1 carries RNA cleavage activity.",
    "llama-2-7b-chat-hf_fact_raw": "1. RNA polymerase II subunit RPB1 carries RNA cleavage activity.",
    "llama-2-7b-chat-hf_fact": [
      "RNA polymerase II subunit RPB1 carries RNA cleavage activity."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: RNA polymerase II subunit RPB1 does not carry RNA cleavage activity. The cleavage activity associated with RNA processing is typically a function of other enzymes like the RNA-induced silencing complex (RISC) or various RNases, not the RNA polymerase itself. RNA polymerase II's primary function is to synthesize messenger RNA (mRNA) from a DNA template.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "llama-2-7b-chat-hf_response": "Ohdo syndrome is caused by mutations in the gene encoding the enzyme hexosaminidase A.",
    "llama-2-7b-chat-hf_fact_raw": "1. Ohdo syndrome is caused by mutations in a gene.\n2. The gene associated with Ohdo syndrome encodes the enzyme hexosaminidase A.",
    "llama-2-7b-chat-hf_fact": [
      "Ohdo syndrome is caused by mutations in a gene.",
      "The gene associated with Ohdo syndrome encodes the enzyme hexosaminidase A."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: The gene most commonly associated with Ohdo syndrome is SALL1, which does not encode the enzyme hexosaminidase A. Instead, it's a transcription factor involved in developmental regulation. Hexosaminidase A is encoded by the HEXA gene and is associated with Tay-Sachs disease, not Ohdo syndrome.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false"
    ]
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "llama-2-7b-chat-hf_response": "One R/Bioconductor package developed for the analysis of psychiatric disease genes is the \"PsychGen\" package.",
    "llama-2-7b-chat-hf_fact_raw": "1. The \"PsychGen\" package is an R/Bioconductor package.\n2. The \"PsychGen\" package is developed for the analysis of psychiatric disease genes.",
    "llama-2-7b-chat-hf_fact": [
      "The \"PsychGen\" package is an R/Bioconductor package.",
      "The \"PsychGen\" package is developed for the analysis of psychiatric disease genes."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n\nWithout specific information on an R/Bioconductor package named \"PsychGen,\" it's not possible to verify these statements as true or false. Such a package may or may not exist and may or may not be for the described purpose. Therefore, unless the content is from a reliable and up-to-date source, the veracity of these statements remains unknown.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "llama-2-7b-chat-hf_response": "The swirl sign is a radiological sign that appears as a spiral or swirling pattern of blood in the affected hemisphere on CT or MRI scans. It is indicative of early intracerebral hemorrhage and can help identify the location and severity of the hemorrhage.",
    "llama-2-7b-chat-hf_fact_raw": "1. The swirl sign is a radiological sign that appears in CT or MRI scans.\n2. The swirl sign displays a spiral or swirling pattern of blood.\n3. The swirl sign is indicative of early intracerebral hemorrhage.\n4. The swirl sign can help identify the location and severity of the hemorrhage.",
    "llama-2-7b-chat-hf_fact": [
      "The swirl sign is a radiological sign that appears in CT or MRI scans.",
      "The swirl sign displays a spiral or swirling pattern of blood.",
      "The swirl sign is indicative of early intracerebral hemorrhage.",
      "The swirl sign can help identify the location and severity of the hemorrhage."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The swirl sign indicates active bleeding within an intracerebral hemorrhage, but it is not necessarily indicative of the early phase of a hemorrhage. It can be seen in both early and late stages.\n4. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "llama-2-7b-chat-hf_response": "Ethylene gas induces Arabidopsis ROF1 expression.",
    "llama-2-7b-chat-hf_fact_raw": "1. Ethylene gas induces Arabidopsis ROF1 expression.",
    "llama-2-7b-chat-hf_fact": [
      "Ethylene gas induces Arabidopsis ROF1 expression."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN\n\nWithout specific research or detailed scientific knowledge relevant to the statement provided, it is not possible to confirm the accuracy of the claim that \"Ethylene gas induces Arabidopsis ROF1 expression.\" This would require specific botanical or molecular biology knowledge or a reliable source confirming the relationship between ethylene gas and the expression of the ROF1 gene in Arabidopsis plants.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "llama-2-7b-chat-hf_response": "The most common cause of hereditary renal amyloidosis is the transthyretin (TTR) protein.",
    "llama-2-7b-chat-hf_fact_raw": "1. The transthyretin (TTR) protein is the most common cause of hereditary renal amyloidosis.",
    "llama-2-7b-chat-hf_fact": [
      "The transthyretin (TTR) protein is the most common cause of hereditary renal amyloidosis."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The transthyretin (TTR) protein is a common cause of hereditary ATTR amyloidosis, which affects the nerves, heart, and other organs, rather than being primarily a cause of hereditary renal amyloidosis. Hereditary renal amyloidosis is more commonly associated with mutations in the genes encoding fibrinogen A alpha-chain, apolipoprotein AI, lysozyme, or apolipoprotein AIV.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "llama-2-7b-chat-hf_response": "Yes, the proteome of the mouse hippocampus has been analyzed.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "llama-2-7b-chat-hf_response": "Yes, mouse chromosomes are acrocentric, meaning that they have a short arm and a long arm that are equally sized. This is in contrast to other mammalian chromosomes, such as human chromosomes, which are metacentric, meaning that the short and long arms are unequal in size.",
    "llama-2-7b-chat-hf_fact_raw": "1. Mouse chromosomes are acrocentric.\n2. Acrocentric chromosomes have a short arm and a long arm that are equally sized.\n3. Human chromosomes are metacentric.\n4. Metacentric chromosomes have short and long arms that are unequal in size.",
    "llama-2-7b-chat-hf_fact": [
      "Mouse chromosomes are acrocentric.",
      "Acrocentric chromosomes have a short arm and a long arm that are equally sized.",
      "Human chromosomes are metacentric.",
      "Metacentric chromosomes have short and long arms that are unequal in size."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: Acrocentric chromosomes have a short arm and a long arm that are not equally sized; the centromere is located close to one end, making one arm significantly shorter than the other.\n3. FALSE [correction]: Not all human chromosomes are metacentric. Humans have metacentric, submetacentric, acrocentric, and telocentric chromosomes.\n4. FALSE [correction]: Metacentric chromosomes have centromeres that are approximately in the middle, making the arms of the chromosome almost equal in length.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "llama-2-7b-chat-hf_response": "The siRNA based drug in clinical trials for the treatment of pancreatic cancer is ONC201.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "llama-2-7b-chat-hf_response": "The HPG pore (Hormone-Protein-Gated pore) is a specialized ion channel that is found in the plasma membrane of certain cells, including pancreatic beta cells and neurons. It allows the passage of specific ions, such as calcium, in response to hormone binding, which is important for cellular signaling and function.",
    "llama-2-7b-chat-hf_fact_raw": "1. The HPG pore is an ion channel found in the plasma membrane of certain cells.\n2. Pancreatic beta cells and neurons are examples of cells that contain the HPG pore.\n3. The HPG pore allows the passage of specific ions, such as calcium.\n4. The activation of the HPG pore is in response to hormone binding.\n5. The HPG pore plays a role in cellular signaling and function.",
    "llama-2-7b-chat-hf_fact": [
      "The HPG pore is an ion channel found in the plasma membrane of certain cells.",
      "Pancreatic beta cells and neurons are examples of cells that contain the HPG pore.",
      "The HPG pore allows the passage of specific ions, such as calcium.",
      "The activation of the HPG pore is in response to hormone binding.",
      "The HPG pore plays a role in cellular signaling and function."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific context or scientific references regarding the \"HPG pore,\" it is difficult to assess the accuracy of these statements. The term \"HPG pore\" is not a standard or widely recognized designation for a specific ion channel in scientific literature, as of my last update. Ion channels do exist in the membranes of various cells and play roles in cellular signaling by allowing the passage of ions, but without further information, the statements regarding the HPG pore cannot be verified.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "llama-2-7b-chat-hf_response": "959 Nematode Genomes is a collaborative research project that aims to sequence the genomes of 959 species of nematodes, which are a group of microscopic worms that are found in soil, plants, and animals. The project aims to provide a comprehensive understanding of the evolution, diversity, and function of nematodes, which are important model organisms in biomedical research.",
    "llama-2-7b-chat-hf_fact_raw": "1. 959 Nematode Genomes is a collaborative research project.\n2. The project aims to sequence the genomes of 959 species of nematodes.\n3. Nematodes are a group of microscopic worms found in soil, plants, and animals.\n4. The project seeks to provide an understanding of evolution, diversity, and function of nematodes.\n5. Nematodes are significant model organisms in biomedical research.",
    "llama-2-7b-chat-hf_fact": [
      "959 Nematode Genomes is a collaborative research project.",
      "The project aims to sequence the genomes of 959 species of nematodes.",
      "Nematodes are a group of microscopic worms found in soil, plants, and animals.",
      "The project seeks to provide an understanding of evolution, diversity, and function of nematodes.",
      "Nematodes are significant model organisms in biomedical research."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: While many nematodes are microscopic, nematodes as a group include a range of sizes, and not all of them are microscopic.\n4. TRUE\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "llama-2-7b-chat-hf_response": "The \"NIPT\" package has been developed for analyzing Non-invasive prenatal testing (NIPT) data.",
    "llama-2-7b-chat-hf_fact_raw": "1. The \"NIPT\" package is used for analyzing Non-invasive prenatal testing (NIPT) data.",
    "llama-2-7b-chat-hf_fact": [
      "The \"NIPT\" package is used for analyzing Non-invasive prenatal testing (NIPT) data."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN\n\n[Note for clarification]: The accuracy of the statement could depend on the specific context or domain being referred to. In genomics and bioinformatics, NIPT could refer to non-invasive prenatal testing, and there could be a package named \"NIPT\" designed for analyzing related data. However, without specific context about the programming environment or the domain, such as whether it's in R, Python, or another platform, and without a known, recognized package with that exact name, it is hard to confirm the truthfulness of the statement.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 2560,
    "user_query": "Describe Achenbachâs syndrome.",
    "llama-2-7b-chat-hf_response": "Achenbach's syndrome is a rare genetic disorder that affects the development of the nervous system. It is characterized by a range of symptoms including intellectual disability, seizures, and abnormalities in the structure and function of the brain and spinal cord.",
    "llama-2-7b-chat-hf_fact_raw": "1. Achenbach's syndrome is a rare genetic disorder.\n2. Achenbach's syndrome affects the development of the nervous system.\n3. Symptoms of Achenbach's syndrome include intellectual disability and seizures.\n4. Achenbach's syndrome involves abnormalities in the structure and function of the brain and spinal cord.",
    "llama-2-7b-chat-hf_fact": [
      "Achenbach's syndrome is a rare genetic disorder.",
      "Achenbach's syndrome affects the development of the nervous system.",
      "Symptoms of Achenbach's syndrome include intellectual disability and seizures.",
      "Achenbach's syndrome involves abnormalities in the structure and function of the brain and spinal cord."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Achenbach's syndrome is not a genetic disorder; it is a condition characterized by spontaneous bruising in the hand or fingers.\n2. FALSE [correction]: Achenbach's syndrome does not primarily affect the development of the nervous system. It is related to paroxysmal hand hematoma.\n3. FALSE [correction]: Symptoms of Achenbach's syndrome do not include intellectual disability and seizures. The primary symptom is spontaneous bruising.\n4. FALSE [correction]: Achenbach's syndrome does not involve abnormalities in the structure and function of the brain and spinal cord. It is mainly associated with bruising in the hands or fingers without a clear cause.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "llama-2-7b-chat-hf_response": "The algorithm used for detection of long repeat expansions is called RepeatMasker.",
    "llama-2-7b-chat-hf_fact_raw": "1. RepeatMasker is an algorithm used for detecting long repeat expansions.",
    "llama-2-7b-chat-hf_fact": [
      "RepeatMasker is an algorithm used for detecting long repeat expansions."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: RepeatMasker is a software tool that is used for identifying repetitive elements in DNA sequences, not specifically for detecting long repeat expansions.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 2582,
    "user_query": "Which brain tumors does neuroligin-3 promote?",
    "llama-2-7b-chat-hf_response": "Neuroligin-3 promotes the growth of medulloblastoma, a type of brain tumor that affects children.",
    "llama-2-7b-chat-hf_fact_raw": "1. Neuroligin-3 promotes the growth of medulloblastoma.\n2. Medulloblastoma is a type of brain tumor.\n3. Medulloblastoma affects children.",
    "llama-2-7b-chat-hf_fact": [
      "Neuroligin-3 promotes the growth of medulloblastoma.",
      "Medulloblastoma is a type of brain tumor.",
      "Medulloblastoma affects children."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2586,
    "user_query": "What is the approximate size of gas vesicles?",
    "llama-2-7b-chat-hf_response": "Gas vesicles are approximately 10-100 nanometers in diameter.",
    "llama-2-7b-chat-hf_fact_raw": "1. Gas vesicles have a diameter ranging from 10 to 100 nanometers.",
    "llama-2-7b-chat-hf_fact": [
      "Gas vesicles have a diameter ranging from 10 to 100 nanometers."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Gas vesicles typically have a diameter ranging from 45 to 200 nanometers.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "llama-2-7b-chat-hf_response": "BET (bromodomain and extraterminal) proteins are a family of proteins that include BRD2, BRD3, and BRDT. These proteins are involved in regulating gene expression by binding to acetylated histones and other proteins.",
    "llama-2-7b-chat-hf_fact_raw": "1. BET stands for bromodomain and extraterminal proteins.\n2. The BET protein family includes BRD2, BRD3, and BRDT.\n3. BET proteins are involved in regulating gene expression.\n4. BET proteins function by binding to acetylated histones and other proteins.",
    "llama-2-7b-chat-hf_fact": [
      "BET stands for bromodomain and extraterminal proteins.",
      "The BET protein family includes BRD2, BRD3, and BRDT.",
      "BET proteins are involved in regulating gene expression.",
      "BET proteins function by binding to acetylated histones and other proteins."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "llama-2-7b-chat-hf_response": "The algorithm developed for prediction of protein subcellular localization using deep learning is called DeepLoc.",
    "llama-2-7b-chat-hf_fact_raw": "1. DeepLoc is an algorithm developed for the prediction of protein subcellular localization.\n2. DeepLoc utilizes deep learning for its predictions.",
    "llama-2-7b-chat-hf_fact": [
      "DeepLoc is an algorithm developed for the prediction of protein subcellular localization.",
      "DeepLoc utilizes deep learning for its predictions."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "llama-2-7b-chat-hf_response": "MULTOVL is a database of molecular structures that are derived from protein-ligand complexes.",
    "llama-2-7b-chat-hf_fact_raw": "1. MULTOVL is a database.\n2. MULTOVL contains molecular structures.\n3. The molecular structures in MULTOVL are derived from protein-ligand complexes.",
    "llama-2-7b-chat-hf_fact": [
      "MULTOVL is a database.",
      "MULTOVL contains molecular structures.",
      "The molecular structures in MULTOVL are derived from protein-ligand complexes."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: MULTOVL is not a database; it stands for \"Multiple Overlap,\" which is an algorithm or tool for comparing and visualizing genomic regions.\n2. FALSE [correction]: Since MULTOVL is not a database, it doesn't contain molecular structures. It's intended for overlapping genomic regions.\n3. FALSE [correction]: Given that MULTOVL is an algorithm for genomic regions and not a database of molecular structures, it does not derive molecular structures from protein-ligand complexes.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "llama-2-7b-chat-hf_response": "Yes, GDF15 can be a biomarker for metformin treatment.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "llama-2-7b-chat-hf_response": "Yes, recursive splicing is more common in short introns.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "llama-2-7b-chat-hf_response": "The TALE-iD method is used for identifying the genomic locations of transcriptional regulatory elements (CREs) by analyzing the DNA sequence and histone modification profiles.",
    "llama-2-7b-chat-hf_fact_raw": "1. The TALE-iD method is used for identifying genomic locations of transcriptional regulatory elements (CREs).\n2. The TALE-iD method analyzes DNA sequence and histone modification profiles.",
    "llama-2-7b-chat-hf_fact": [
      "The TALE-iD method is used for identifying genomic locations of transcriptional regulatory elements (CREs).",
      "The TALE-iD method analyzes DNA sequence and histone modification profiles."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown"
    ]
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "llama-2-7b-chat-hf_response": "CL (Common Lisp).",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "llama-2-7b-chat-hf_response": "1000.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor Î² (Esrrb)?",
    "llama-2-7b-chat-hf_response": "The complex bound by estrogen-related receptor Î² (Esrrb) is estradiol.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "llama-2-7b-chat-hf_response": "ZCCHC17 is a zinc finger protein that is involved in regulating gene expression, particularly in the context of cancer. It is thought to play a role in the epigenetic modification of histone proteins, leading to changes in chromatin structure and gene expression.",
    "llama-2-7b-chat-hf_fact_raw": "1. ZCCHC17 is a zinc finger protein.\n2. ZCCHC17 is involved in regulating gene expression.\n3. ZCCHC17's role is particularly significant in the context of cancer.\n4. It is thought that ZCCHC17 plays a role in the epigenetic modification of histone proteins.\n5. ZCCHC17 is associated with changes in chromatin structure and gene expression.",
    "llama-2-7b-chat-hf_fact": [
      "ZCCHC17 is a zinc finger protein.",
      "ZCCHC17 is involved in regulating gene expression.",
      "ZCCHC17's role is particularly significant in the context of cancer.",
      "It is thought that ZCCHC17 plays a role in the epigenetic modification of histone proteins.",
      "ZCCHC17 is associated with changes in chromatin structure and gene expression."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "llama-2-7b-chat-hf_response": "The nuclear pore basket in human cells is formed by proteins called Nup107 and Nup133.",
    "llama-2-7b-chat-hf_fact_raw": "1. The nuclear pore basket in human cells is formed by the proteins Nup107 and Nup133.",
    "llama-2-7b-chat-hf_fact": [
      "The nuclear pore basket in human cells is formed by the proteins Nup107 and Nup133."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The nuclear pore basket in human cells is not formed solely by the proteins Nup107 and Nup133. The nuclear pore basket is a structure that is part of the nuclear pore complex (NPC), which includes multiple different proteins known as nucleoporins. The basket is thought to be primarily composed of nucleoporins such as Tpr, Nup153, and several others, but not exclusively by Nup107 and Nup133. The Nup107-160 complex, which includes Nup107 and Nup133 among others, is involved in the overall structure and function of the NPC but is not the sole component of the nuclear basket.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "llama-2-7b-chat-hf_response": "Gepotidacin is a DNA minor groove bindin g topoisomerase 1 inhibitor.",
    "llama-2-7b-chat-hf_fact_raw": "1. Gepotidacin is a topoisomerase inhibitor.\n2. Gepotidacin inhibits topoisomerase 1.\n3. Gepotidacin binds to the DNA minor groove.",
    "llama-2-7b-chat-hf_fact": [
      "Gepotidacin is a topoisomerase inhibitor.",
      "Gepotidacin inhibits topoisomerase 1.",
      "Gepotidacin binds to the DNA minor groove."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: Gepotidacin inhibits bacterial topoisomerase II (DNA gyrase) and topoisomerase IV.\n3. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "llama-2-7b-chat-hf_response": "Canvas SPW stands for Canvas Sub-Pixel Wavefront. It is a technology used in digital displays to improve image quality and reduce eye strain. The technology uses a sub-pixel structure to split each pixel into three sub-pixels, which are controlled independently to produce a more accurate and detailed image. Canvas SPW helps in reducing the risk of eye fatigue and improving the overall viewing experience, especially in applications such as gaming and video streaming.",
    "llama-2-7b-chat-hf_fact_raw": "1. Canvas SPW stands for Canvas Sub-Pixel Wavefront.\n2. Canvas SPW is used in digital displays to improve image quality.\n3. The technology splits each pixel into three sub-pixels.\n4. Each sub-pixel in Canvas SPW can be controlled independently.\n5. Canvas SPW is designed to reduce eye strain and fatigue.",
    "llama-2-7b-chat-hf_fact": [
      "Canvas SPW stands for Canvas Sub-Pixel Wavefront.",
      "Canvas SPW is used in digital displays to improve image quality.",
      "The technology splits each pixel into three sub-pixels.",
      "Each sub-pixel in Canvas SPW can be controlled independently.",
      "Canvas SPW is designed to reduce eye strain and fatigue."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Canvas SPW does not have a widely recognized meaning in technology or digital displays; therefore, it is likely incorrect or a fictional term.\n2. FALSE [correction]: Since Canvas SPW is not a recognized term, it cannot be used in digital displays to improve image quality.\n3. UNKNOWN: The description could refer to a pixel structure that is used in some display technologies where each pixel is comprised of three sub-pixels (often red, green, and blue). However, without a correct reference to \"Canvas SPW,\" this statement's accuracy is indeterminate.\n4. UNKNOWN: While it is true that some display technologies allow for independent control of sub-pixels, the reference to \"Canvas SPW\" remains unclear, making the statement's accuracy difficult to assess.\n5. UNKNOWN: Without accurate information about what \"Canvas SPW\" refers to, it is impossible to validate this statement. However, many display technologies aim to reduce eye strain and fatigue but without the correct context, this statement cannot be verified.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "llama-2-7b-chat-hf_response": "Some examples of STING agonists include cyclic dinucleotides (CDNs) such as cGAMP and 2'-O-Me-cGAMP, and small molecule agonists such as RX-0201 and RX-0202.",
    "llama-2-7b-chat-hf_fact_raw": "1. Cyclic dinucleotides (CDNs) are a type of STING agonist.\n2. cGAMP is an example of a STING agonist.\n3. 2'-O-Me-cGAMP is an example of a STING agonist.\n4. RX-0201 is a small molecule STING agonist.\n5. RX-0202 is a small molecule STING agonist.",
    "llama-2-7b-chat-hf_fact": [
      "Cyclic dinucleotides (CDNs) are a type of STING agonist.",
      "cGAMP is an example of a STING agonist.",
      "2'-O-Me-cGAMP is an example of a STING agonist.",
      "RX-0201 is a small molecule STING agonist.",
      "RX-0202 is a small molecule STING agonist."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "llama-2-7b-chat-hf_response": "SLIC-CAGE (Sparse Linear Independent Component Analysis with Clustering and Grouping) is a computational method used to identify and separate protein complexes in a protein sample. It is an extension of the original CAGE (Comprehensive Automated Global Epitope) method, which only considered the global distribution of protein abundance.\nSLIC-CAGE combines the global analysis of CAGE with a local analysis of protein abundance, using a sparse linear independent component analysis (LICA) to identify clusters of proteins that are highly correlated in their abundance patterns. This allows for the separation of protein complexes from individual proteins, even in the presence of high levels of noise or low abundance of certain proteins.\nThe method starts by mapping the protein sample to a two-dimensional representation, where each protein is represented by a point in the plane. The points are then clustered using a hierarchical clustering algorithm, such as k-means or hierarchical clustering. The clusters are then used to identify the protein complexes in the sample.\nSLIC-CAGE has been shown to be highly effective in identifying protein complexes in a variety of biological samples, including those derived from cells, tissues, and organisms. It has also been used to study the dynamics of protein complexes over time, and to identify protein complexes that are involved in specific biological processes or diseases.\nOverall, SLIC-CAGE is a powerful tool for the analysis of protein complexes, and has contributed significantly to our understanding of the structure and function of protein networks in biological systems.",
    "llama-2-7b-chat-hf_fact_raw": "1. SLIC-CAGE is a computational method that identifies and separates protein complexes in a protein sample.\n2. SLIC-CAGE is an extension of the original Comprehensive Automated Global Epitope (CAGE) method.\n3. The method combines global analysis with local analysis of protein abundance using sparse linear independent component analysis (LICA) to identify clusters of correlated proteins.\n4. SLIC-CAGE uses a two-dimensional representation to map protein samples, following which clustering algorithms like k-means or hierarchical clustering are applied.\n5. The effectiveness of SLIC-CAGE has been demonstrated in identifying protein complexes in various biological samples such as cells, tissues, and organisms.",
    "llama-2-7b-chat-hf_fact": [
      "SLIC-CAGE is a computational method that identifies and separates protein complexes in a protein sample.",
      "SLIC-CAGE is an extension of the original Comprehensive Automated Global Epitope (CAGE) method.",
      "The method combines global analysis with local analysis of protein abundance using sparse linear independent component analysis (LICA) to identify clusters of correlated proteins.",
      "SLIC-CAGE uses a two-dimensional representation to map protein samples, following which clustering algorithms like k-means or hierarchical clustering are applied.",
      "The effectiveness of SLIC-CAGE has been demonstrated in identifying protein complexes in various biological samples such as cells, tissues, and organisms."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: The method description seems to refer to the general technique of analyzing protein data using computational methods, but \"sparse linear independent component analysis (LICA)\" is incorrect. Instead, it should be \"Sparse Learning of Instrumental Variables via Conditional Analysis (SLIC-CAGE)\" which does a different form of analysis.\n4. UNKNOWN\n5. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "llama-2-7b-chat-hf_response": "LEM-3 is involved in the regulation of endosomal sorting and the degradation of proteins, particularly those involved in cell signaling pathways. It also plays a role in the regulation of autophagy.",
    "llama-2-7b-chat-hf_fact_raw": "1. LEM-3 is involved in the regulation of endosomal sorting.\n2. LEM-3 has a role in the degradation of proteins.\n3. LEM-3 is particularly involved in the degradation of proteins in cell signaling pathways.\n4. LEM-3 plays a role in the regulation of autophagy.",
    "llama-2-7b-chat-hf_fact": [
      "LEM-3 is involved in the regulation of endosomal sorting.",
      "LEM-3 has a role in the degradation of proteins.",
      "LEM-3 is particularly involved in the degradation of proteins in cell signaling pathways.",
      "LEM-3 plays a role in the regulation of autophagy."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: LEM-3 is not directly involved in protein degradation; instead, it is involved in DNA damage repair processes.\n3. FALSE [correction]: As LEM-3 is involved in DNA damage repair processes, it is not directly involved in the degradation of proteins in cell signaling pathways.\n4. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "llama-2-7b-chat-hf_response": "TMVar is a gene that is involved in the development and maintenance of the nervous system. There are several releases of TMVar, including TMVar1, TMVar2, and TMVar3.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "llama-2-7b-chat-hf_response": "The database of somatic mutations in normal cells is called the Cancer Genome Atlas (TCGA).",
    "llama-2-7b-chat-hf_fact_raw": "1. The Cancer Genome Atlas (TCGA) is a database of somatic mutations in normal cells.",
    "llama-2-7b-chat-hf_fact": [
      "The Cancer Genome Atlas (TCGA) is a database of somatic mutations in normal cells."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The Cancer Genome Atlas (TCGA) is a database that contains genetic information from thousands of cancer patients, including somatic mutations in cancerous cells, not normal cells.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "llama-2-7b-chat-hf_response": "Yes, there are several graph kernel libraries available implemented in Java, including NetworkX and igraph.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "llama-2-7b-chat-hf_response": "The SHERLOCKv2 platform integrates four advances in biomedicine:\n1. CRISPR-Cas13 technology for targeted gene expression and epigenetic regulation.\n2. Single-molecule FISH (smFISH) for high-resolution imaging of gene expression and epigenetic marks.\n3. Synthetic biology tools for gene circuit design and optimization.\n4. Machine learning algorithms for predictive modeling and automated analysis of large-scale biological data.\nThese advances enable the SHERLOCKv2 platform to perform a wide range of applications in biomedicine, including gene therapy, gene editing, and single-cell analysis.",
    "llama-2-7b-chat-hf_fact_raw": "1. The SHERLOCKv2 platform integrates CRISPR-Cas13 technology.\n2. The SHERLOCKv2 platform uses single-molecule FISH (smFISH) for imaging.\n3. Synthetic biology tools are part of the SHERLOCKv2 platform's capabilities.\n4. Machine learning algorithms are utilized in the SHERLOCKv2 platform for analysis.",
    "llama-2-7b-chat-hf_fact": [
      "The SHERLOCKv2 platform integrates CRISPR-Cas13 technology.",
      "The SHERLOCKv2 platform uses single-molecule FISH (smFISH) for imaging.",
      "Synthetic biology tools are part of the SHERLOCKv2 platform's capabilities.",
      "Machine learning algorithms are utilized in the SHERLOCKv2 platform for analysis."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: The SHERLOCKv2 platform does not use single-molecule FISH for imaging, it is a CRISPR-based technology for nucleic acid detection.\n3. TRUE\n4. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "llama-2-7b-chat-hf_response": "The Bartender algorithm is a computational method used to predict the binding affinity of transcription factors (TFs) to their target DNA sequences. It was developed by researchers at the University of California, San Diego and is based on the concept of \"bartending,\" where the algorithm mixes and matches different DNA sequences to create a new sequence with optimal binding affinity for a given TF. The algorithm uses a combination of sequence composition and structural information to predict the binding affinity of TFs to their target sequences. By analyzing the sequence composition of the target site and the structural properties of the TF-DNA complex, the Bartender algorithm can predict the binding affinity of the TF to the target site, providing valuable insights into the regulation of gene expression.",
    "llama-2-7b-chat-hf_fact_raw": "1. The Bartender algorithm is used to predict the binding affinity of transcription factors to their target DNA sequences.\n2. It was developed by researchers at the University of California, San Diego.\n3. The Bartender algorithm is based on mixing and matching different DNA sequences to create an optimal binding affinity.\n4. The algorithm uses sequence composition and structural information in its predictions.\n5. The Bartender algorithm provides insights into the regulation of gene expression.",
    "llama-2-7b-chat-hf_fact": [
      "The Bartender algorithm is used to predict the binding affinity of transcription factors to their target DNA sequences.",
      "It was developed by researchers at the University of California, San Diego.",
      "The Bartender algorithm is based on mixing and matching different DNA sequences to create an optimal binding affinity.",
      "The algorithm uses sequence composition and structural information in its predictions.",
      "The Bartender algorithm provides insights into the regulation of gene expression."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Bartender algorithm does not involve mixing and matching DNA sequences; instead, it identifies and assesses transcription factor binding sites based on a set of parameters including sequence and structure.\n4. TRUE\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "llama-2-7b-chat-hf_response": "Some web-based pedigree editors available include Pedigree-Editor, Pedigree-Builder, and Family Tree Builder.",
    "llama-2-7b-chat-hf_fact_raw": "1. Pedigree-Editor is available as a web-based pedigree editor.\n2. Pedigree-Builder is available as a web-based pedigree editor.\n3. Family Tree Builder is available as a web-based pedigree editor.",
    "llama-2-7b-chat-hf_fact": [
      "Pedigree-Editor is available as a web-based pedigree editor.",
      "Pedigree-Builder is available as a web-based pedigree editor.",
      "Family Tree Builder is available as a web-based pedigree editor."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: Pedigree-Builder is not a well-known web-based pedigree editor; however, without specific information about a product with that name, the accuracy of this statement cannot be confirmed.\n3. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "llama-2-7b-chat-hf_response": "2 curated databases exist for spider-venom toxins: ToxinDB and SpiderTox.",
    "llama-2-7b-chat-hf_fact_raw": "1. ToxinDB is a curated database for spider-venom toxins.\n2. SpiderTox is a curated database for spider-venom toxins.",
    "llama-2-7b-chat-hf_fact": [
      "ToxinDB is a curated database for spider-venom toxins.",
      "SpiderTox is a curated database for spider-venom toxins."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: SpiderTox is not a curated database; ArachnoServer is the correct curated database for spider-venom toxins.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false"
    ]
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "llama-2-7b-chat-hf_response": "No, Axitinib does not prolong survival of Pancreatic Cancer patients.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3113,
    "user_query": "Through which protein interaction does MLP regulate F-actin dynamics?",
    "llama-2-7b-chat-hf_response": "MLP regulates F-actin dynamics through its interaction with the actin-binding protein cofilin.",
    "llama-2-7b-chat-hf_fact_raw": "1. MLP regulates F-actin dynamics.\n2. MLP interacts with the actin-binding protein cofilin.",
    "llama-2-7b-chat-hf_fact": [
      "MLP regulates F-actin dynamics.",
      "MLP interacts with the actin-binding protein cofilin."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n\nWithout the specific context or relevant reference materials to confirm these statements on myelin protein zero (MLP) and its interactions with F-actin dynamics or the actin-binding protein cofilin, I cannot determine the veracity of these statements. These statements require specific biological knowledge or literature that would provide evidence for such claims.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3125,
    "user_query": "How many pseudokinases are there in the human kinome?",
    "llama-2-7b-chat-hf_response": "100",
    "llama-2-7b-chat-hf_fact_raw": "1. There are 100 pseudokinases in the human kinome.",
    "llama-2-7b-chat-hf_fact": [
      "There are 100 pseudokinases in the human kinome."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN\n\nRationale: To determine the truth of this statement, we would need specific data on the number of pseudokinases in the human kinome. This information could depend on current biological research and the criteria used to classify kinases and pseudokinases. Without precise and up-to-date scientific references, it is not possible to confirm or refute the exact number stated.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "llama-2-7b-chat-hf_response": "3 apoE mimetics are:\n1. ApoA-I mimetic peptide\n2. ApoA-I mimetic liposomes\n3. ApoA-I mimetic nanoparticles.",
    "llama-2-7b-chat-hf_fact_raw": "1. ApoA-I mimetic peptide is an apoE mimetic.\n2. ApoA-I mimetic liposomes are apoE mimetics.\n3. ApoA-I mimetic nanoparticles are apoE mimetics.",
    "llama-2-7b-chat-hf_fact": [
      "ApoA-I mimetic peptide is an apoE mimetic.",
      "ApoA-I mimetic liposomes are apoE mimetics.",
      "ApoA-I mimetic nanoparticles are apoE mimetics."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: ApoA-I mimetic peptides are not apoE mimetics. They are designed to mimic the properties of apolipoprotein A-I (ApoA-I), not apolipoprotein E (apoE).\n2. FALSE [correction]: ApoA-I mimetic liposomes mimic the properties of apolipoprotein A-I (ApoA-I), not apolipoprotein E (apoE).\n3. FALSE [correction]: ApoA-I mimetic nanoparticles are designed to mimic the properties of apolipoprotein A-I, not apolipoprotein E.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "llama-2-7b-chat-hf_response": "There are sex differences in SAMHD1 activity, with males having higher activity than females.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "llama-2-7b-chat-hf_response": "No.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3209,
    "user_query": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
    "llama-2-7b-chat-hf_response": "The Cobb-Stainsby excision arthroplasty is performed in the knee joint.",
    "llama-2-7b-chat-hf_fact_raw": "1. The Cobb-Stainsby excision arthroplasty is a procedure performed on the knee joint.",
    "llama-2-7b-chat-hf_fact": [
      "The Cobb-Stainsby excision arthroplasty is a procedure performed on the knee joint."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The Cobb-Stainsby excision arthroplasty is a procedure performed on the hip joint, not the knee joint.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "llama-2-7b-chat-hf_response": "Yes, GRHL2 over-expression leads to EMT.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "llama-2-7b-chat-hf_response": "T-bet, Eomesodermin, and Foxp1 have been implicated in lung cancer.",
    "llama-2-7b-chat-hf_fact_raw": "1. T-bet has been implicated in lung cancer.\n2. Eomesodermin has been implicated in lung cancer.\n3. Foxp1 has been implicated in lung cancer.",
    "llama-2-7b-chat-hf_fact": [
      "T-bet has been implicated in lung cancer.",
      "Eomesodermin has been implicated in lung cancer.",
      "Foxp1 has been implicated in lung cancer."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE: T-bet, a T-box transcription factor also known as TBX21, has been implicated in various forms of cancer, including lung cancer, through its role in immune responses and involvement in Th1 cell differentiation.\n2. UNKNOWN: Eomesodermin, another T-box transcription factor also known as Eomes, plays roles in immune regulation. While it has been studied in the context of cancer immunology, its direct implication in lung cancer is not as clearly established and may depend on the specific context or type of lung cancer.\n3. TRUE: Foxp1, or Forkhead box protein P1, has been implicated in a variety of cancers, including lung cancer. It is known to play roles in cell growth, proliferation, and differentiation, and alterations in Foxp1 expression have been linked to tumorigenesis.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "llama-2-7b-chat-hf_response": "GPR151 (G protein-coupled receptor 151) is an orphan receptor, meaning that it does not have a well-defined endogenous ligand. However, it has been shown to be activated by a variety of ligands, including fatty acids and retinoic acid. Activation of GPR151 leads to the activation of downstream signaling pathways, including the G alpha subunit of the G protein complex. GPR151 is primarily expressed in the brain, where it has been implicated in the regulation of feeding behavior and energy homeostasis. It is also expressed in other tissues, including the pancreas, where it may play a role in the regulation of insulin secretion.",
    "llama-2-7b-chat-hf_fact_raw": "1. GPR151 stands for G protein-coupled receptor 151.\n2. GPR151 does not have a well-defined endogenous ligand.\n3. It can be activated by various ligands such as fatty acids and retinoic acid.\n4. Activation of GPR151 leads to the activation of downstream signaling pathways, including the G alpha subunit of the G protein complex.\n5. GPR151 is primarily expressed in the brain and has been implicated in the regulation of feeding behavior and energy homeostasis.",
    "llama-2-7b-chat-hf_fact": [
      "GPR151 stands for G protein-coupled receptor 151.",
      "GPR151 does not have a well-defined endogenous ligand.",
      "It can be activated by various ligands such as fatty acids and retinoic acid.",
      "Activation of GPR151 leads to the activation of downstream signaling pathways, including the G alpha subunit of the G protein complex.",
      "GPR151 is primarily expressed in the brain and has been implicated in the regulation of feeding behavior and energy homeostasis."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements about the specifics of GPR151 function, its endogenous ligands, and its role in physiology require specialized knowledge in biochemistry or a specific field of biological research, for which the details have not been provided in the context. Therefore, without additional context or research into the current understanding of GPR151, the veracity of statements 3, 4, and 5 cannot be determined.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "llama-2-7b-chat-hf_response": "The Fluzone intradermal quadrivalent vaccine contains attenuated live viruses for the following four strains:\n1. Influenza A (H1N1)\n2. Influenza A (H3N2)\n3. Influenza B (Victoria lineage)\n4. Influenza B (Yamagata lineage)",
    "llama-2-7b-chat-hf_fact_raw": "1. The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus for Influenza A (H1N1).\n2. The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus for Influenza A (H3N2).\n3. The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus for Influenza B (Victoria lineage).\n4. The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus for Influenza B (Yamagata lineage).",
    "llama-2-7b-chat-hf_fact": [
      "The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus for Influenza A (H1N1).",
      "The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus for Influenza A (H3N2).",
      "The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus for Influenza B (Victoria lineage).",
      "The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus for Influenza B (Yamagata lineage)."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The Fluzone intradermal quadrivalent vaccine does not contain a live virus; it is an inactivated vaccine.\n2. FALSE [correction]: The Fluzone intradermal quadrivalent vaccine does not contain a live virus; it is an inactivated vaccine.\n3. FALSE [correction]: The Fluzone intradermal quadrivalent vaccine does not contain a live virus; it is an inactivated vaccine.\n4. FALSE [correction]: The Fluzone intradermal quadrivalent vaccine does not contain a live virus; it is an inactivated vaccine.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "llama-2-7b-chat-hf_response": "The genetic association of Systemic Lupus Erythematosus (SLE) has been identified in the TNFR2 gene, specifically in the promoter region.",
    "llama-2-7b-chat-hf_fact_raw": "1. The TNFR2 gene is genetically associated with Systemic Lupus Erythematosus (SLE).\n2. The promoter region of the TNFR2 gene is specifically associated with Systemic Lupus Erythematosus.",
    "llama-2-7b-chat-hf_fact": [
      "The TNFR2 gene is genetically associated with Systemic Lupus Erythematosus (SLE).",
      "The promoter region of the TNFR2 gene is specifically associated with Systemic Lupus Erythematosus."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE: The TNFR2 gene has been reported to have genetic associations with Systemic Lupus Erythematosus (SLE) according to scientific studies.\n2. UNKNOWN: The specific association of the promoter region of the TNFR2 gene with Systemic Lupus Erythematosus requires more detailed information or specific studies to confirm its validity; therefore, without specific evidence, this statement is difficult to determine as true or false.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown"
    ]
  },
  {
    "id": 3353,
    "user_query": "Is there a vaccine for peanut allergy?",
    "llama-2-7b-chat-hf_response": "No, there is no vaccine for peanut allergy.",
    "llama-2-7b-chat-hf_fact_raw": "1. There is no vaccine for peanut allergy.",
    "llama-2-7b-chat-hf_fact": [
      "There is no vaccine for peanut allergy."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "llama-2-7b-chat-hf_response": "The mouse Fxy gene is located on the X chromosome.",
    "llama-2-7b-chat-hf_fact_raw": "1. The mouse Fxy gene is located on the X chromosome.",
    "llama-2-7b-chat-hf_fact": [
      "The mouse Fxy gene is located on the X chromosome."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "llama-2-7b-chat-hf_response": "The basis of the method is the incorporation of a modified base, methylpropyl-EDTA (methylpropyl-ethyl-bis-Î²-aminoethyl-glycine (MEBG)), during DNA synthesis, which allows for the selective amplification of the modified DNA strands.",
    "llama-2-7b-chat-hf_fact_raw": "1. Methidiumpropyl-EDTA sequencing (MPE-seq) method incorporates a modified base called methylpropyl-EDTA (MEBG) during DNA synthesis.\n2. The incorporation of MEBG allows for the selective amplification of the modified DNA strands.",
    "llama-2-7b-chat-hf_fact": [
      "Methidiumpropyl-EDTA sequencing (MPE-seq) method incorporates a modified base called methylpropyl-EDTA (MEBG) during DNA synthesis.",
      "The incorporation of MEBG allows for the selective amplification of the modified DNA strands."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Methidiumpropyl-EDTA sequencing (MPE-seq) does not incorporate a modified base called methylpropyl-EDTA (MEBG) during DNA synthesis. Instead, MPE-seq uses methidiumpropyl-EDTA-Fe(II) (MPE) as a cleaving agent to fragment DNA at protein-binding sites.\n2. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown"
    ]
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "llama-2-7b-chat-hf_response": "Python.",
    "llama-2-7b-chat-hf_fact_raw": "1. Python is the programming language used to implement GWAR.",
    "llama-2-7b-chat-hf_fact": [
      "Python is the programming language used to implement GWAR."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "llama-2-7b-chat-hf_response": "Xaliproden has been shown to improve prognosis in patients with amyotrophic lateral sclerosis (ALS).",
    "llama-2-7b-chat-hf_fact_raw": "1. Xaliproden improves prognosis in patients with amyotrophic lateral sclerosis (ALS).",
    "llama-2-7b-chat-hf_fact": [
      "Xaliproden improves prognosis in patients with amyotrophic lateral sclerosis (ALS)."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n\nWithout the specific context or results from clinical studies explicitly provided, it is not possible to conclusively determine whether Xaliproden improves prognosis in patients with amyotrophic lateral sclerosis (ALS) as current knowledge up to the early months of 2023 suggests that the efficacy of potential treatments such as Xaliproden can vary and the statement doesn't provide information on specific studies, trial results, or the current consensus on the treatment's effectiveness.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "llama-2-7b-chat-hf_response": "The LiPS-A3S line has transgenes inserted into chromosome III.",
    "llama-2-7b-chat-hf_fact_raw": "1. The LiPS-A3S line has transgenes inserted into chromosome III.",
    "llama-2-7b-chat-hf_fact": [
      "The LiPS-A3S line has transgenes inserted into chromosome III."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "llama-2-7b-chat-hf_response": "One tool that exists for predicting drug synergy with deep learning is DeepSynth.",
    "llama-2-7b-chat-hf_fact_raw": "1. DeepSynth is a tool for predicting drug synergy with deep learning.",
    "llama-2-7b-chat-hf_fact": [
      "DeepSynth is a tool for predicting drug synergy with deep learning."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "llama-2-7b-chat-hf_response": "The cloud-based platform developed for comparing GWAS is called CloudGenomics.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "llama-2-7b-chat-hf_response": "CMB305 is not typically used as a treatment for sarcomas, as it is primarily used for the treatment of pancreatic cancer.",
    "llama-2-7b-chat-hf_fact_raw": "1. CMB305 is primarily used for the treatment of pancreatic cancer.\n2. CMB305 is not typically used as a treatment for sarcomas.",
    "llama-2-7b-chat-hf_fact": [
      "CMB305 is primarily used for the treatment of pancreatic cancer.",
      "CMB305 is not typically used as a treatment for sarcomas."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: CMB305 is a treatment that has been under investigation for use in patients with certain types of sarcoma.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "false"
    ]
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "llama-2-7b-chat-hf_response": "The manifestations of the Saint's Triad are a set of three symptoms that are commonly seen in patients with mitochondrial disorders, including muscle weakness, encephalopathy (brain disease), and seizures.",
    "llama-2-7b-chat-hf_fact_raw": "1. The Saint's Triad includes muscle weakness.\n2. Encephalopathy is a symptom of the Saint's Triad.\n3. Seizures are part of the manifestations of the Saint's Triad.",
    "llama-2-7b-chat-hf_fact": [
      "The Saint's Triad includes muscle weakness.",
      "Encephalopathy is a symptom of the Saint's Triad.",
      "Seizures are part of the manifestations of the Saint's Triad."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN: The term \"Saint's Triad\" is not a standard medical term and without additional context it's unclear what the \"Saint's Triad\" refers to. It might be a reference to a specific condition or a colloquial name for a group of symptoms, but without further context, it's not possible to determine the accuracy of the statement.\n2. UNKNOWN: For the same reasons mentioned for statement 1, it's impossible to accurately label this statement true or false without additional context.\n3. UNKNOWN: Similarly to the previous statements, without specific context, it's unclear what the \"Saint's Triad\" refers to, making it impossible to determine the truth of this statement.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "llama-2-7b-chat-hf_response": "Yes, overexpression of LY6K has been associated with better prognosis for non-small cell lung cancer patients.",
    "llama-2-7b-chat-hf_fact_raw": "1. Overexpression of LY6K is associated with better prognosis for non-small cell lung cancer patients.",
    "llama-2-7b-chat-hf_fact": [
      "Overexpression of LY6K is associated with better prognosis for non-small cell lung cancer patients."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Overexpression of LY6K is generally associated with a worse prognosis for non-small cell lung cancer patients.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "llama-2-7b-chat-hf_response": "Cdk targets that are dephosphorylated during cytokinesis include:\n1. Cyclin-dependent kinase 1 (Cdk1)\n2. Cyclin-dependent kinase 2 (Cdk2)\n3. Cyclin-dependent kinase 5 (Cdk5)\n4. Cyclin-dependent kinase 6 (Cdk6)\n5. Cyclin-dependent kinase 7 (Cdk7)",
    "llama-2-7b-chat-hf_fact_raw": "1. Cyclin-dependent kinase 1 (Cdk1) is dephosphorylated during cytokinesis.\n2. Cyclin-dependent kinase 2 (Cdk2) is dephosphorylated during cytokinesis.\n3. Cyclin-dependent kinase 5 (Cdk5) is dephosphorylated during cytokinesis.\n4. Cyclin-dependent kinase 6 (Cdk6) is dephosphorylated during cytokinesis.\n5. Cyclin-dependent kinase 7 (Cdk7) is dephosphorylated during cytokinesis.",
    "llama-2-7b-chat-hf_fact": [
      "Cyclin-dependent kinase 1 (Cdk1) is dephosphorylated during cytokinesis.",
      "Cyclin-dependent kinase 2 (Cdk2) is dephosphorylated during cytokinesis.",
      "Cyclin-dependent kinase 5 (Cdk5) is dephosphorylated during cytokinesis.",
      "Cyclin-dependent kinase 6 (Cdk6) is dephosphorylated during cytokinesis.",
      "Cyclin-dependent kinase 7 (Cdk7) is dephosphorylated during cytokinesis."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements refer to specific molecular events that occur during the cell cycle. Phosphorylation and dephosphorylation of cyclin-dependent kinases (Cdks) are mechanisms that regulate the cell cycle, but without specific scientific context or data, it's not possible to verify these statements as generally true, false, or to provide corrections. Phosphorylation status of Cdks can vary depending on the phase of the cell cycle, and it is subject to complex regulation. Therefore, a detailed knowledge of the specific research or scientific literature that the statements are derived from is necessary to accurately assess these claims.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "llama-2-7b-chat-hf_response": "Xanamem is a drug used to treat severe pain, particularly in the context of cancer.",
    "llama-2-7b-chat-hf_fact_raw": "1. Xanamem is a drug used to treat severe pain.\n2. Xanamem is used particularly in the context of cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Xanamem is a drug used to treat severe pain.",
      "Xanamem is used particularly in the context of cancer."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Xanamem is not a recognized drug for treating severe pain. As of my knowledge cutoff date in 2023, Xanamem is not a known medication in pharmacology.\n2. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown"
    ]
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "llama-2-7b-chat-hf_response": "The Hof1-Cyk3 interaction in yeast regulates the localization of the Hof1 protein to the cytoplasm.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "llama-2-7b-chat-hf_response": "Î²-catenin and TP53 have been implicated in gastric cancer.",
    "llama-2-7b-chat-hf_fact_raw": "1. Î²-catenin has been implicated in gastric cancer.\n2. TP53 has been implicated in gastric cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Î²-catenin has been implicated in gastric cancer.",
      "TP53 has been implicated in gastric cancer."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE: Î²-catenin has been implicated in various types of cancers, including gastric cancer, where alterations in the Wnt/Î²-catenin signaling pathway can play a role in the development and progression of the disease.\n\n2. TRUE: TP53, which encodes for the p53 protein, is known as a tumor suppressor gene and has been implicated in a wide range of cancers, including gastric cancer. Mutations in the TP53 gene can contribute to the development and progression of gastric cancer.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "llama-2-7b-chat-hf_response": "The Lupus Severity Index (LSI) is a tool used to assess the severity of systemic lupus erythematosus (SLE) based on the patient's symptoms, laboratory test results, and organ damage.",
    "llama-2-7b-chat-hf_fact_raw": "1. The Lupus Severity Index is used to assess the severity of systemic lupus erythematosus.\n2. The LSI takes into account the patient's symptoms.\n3. The LSI considers laboratory test results for assessment.\n4. The LSI evaluates organ damage in the patient.",
    "llama-2-7b-chat-hf_fact": [
      "The Lupus Severity Index is used to assess the severity of systemic lupus erythematosus.",
      "The LSI takes into account the patient's symptoms.",
      "The LSI considers laboratory test results for assessment.",
      "The LSI evaluates organ damage in the patient."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n\nExplanation:\nWhile the Lupus Severity Index (LSI) could logically be involved in assessing various aspects of systemic lupus erythematosus, including symptoms, laboratory test results, and organ damage, without specific and detailed information about the LSI and its criteria, it is not possible to definitively state what exactly it takes into account or evaluates. Therefore, statements 2, 3, and 4 cannot be accurately verified without additional context. The LSI is not a commonly known or standardized term in medical literature compared to other indices such as SLEDAI (Systemic Lupus Erythematosus Disease Activity Index) or SLICC (Systemic Lupus International Collaborating Clinics). These more familiar indices include assessment of symptoms, laboratory results, and organ damage. If the LSI is meant to refer to one of these or a similar tool, then the information provided would be insufficient to determine the truth value of the statements without additional context.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "llama-2-7b-chat-hf_response": "De novo mutations in ZSWIM6 have been associated with several disorders, including intellectual disability, seizures, and autism spectrum disorder.",
    "llama-2-7b-chat-hf_fact_raw": "1. De novo mutations in ZSWIM6 are associated with intellectual disability.\n2. De novo mutations in ZSWIM6 are associated with seizures.\n3. De novo mutations in ZSWIM6 are associated with autism spectrum disorder.",
    "llama-2-7b-chat-hf_fact": [
      "De novo mutations in ZSWIM6 are associated with intellectual disability.",
      "De novo mutations in ZSWIM6 are associated with seizures.",
      "De novo mutations in ZSWIM6 are associated with autism spectrum disorder."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE: De novo mutations in ZSWIM6 have been associated with intellectual disability in the literature.\n2. UNKNOWN: Without specific literature or evidence provided for the association between ZSWIM6 mutations and seizures, the truth of this statement cannot be confirmed.\n3. UNKNOWN: While some genetic mutations can be associated with autism spectrum disorder, without specific context or references, the association between de novo mutations in ZSWIM6 and autism spectrum disorder cannot be confirmed.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "llama-2-7b-chat-hf_response": "Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "llama-2-7b-chat-hf_response": "AZD8601 is a small molecule inhibitor of the enzyme diacylglycerol acyltransferase 1 (DGAT1). In vivo, AZD8601 reduces the synthesis of triacylglycerols in the liver, leading to decreased liver triglyceride content and improved insulin sensitivity. Additionally, AZD8601 has been shown to reduce inflammation in various tissues, including the liver, and may have potential as a treatment for non-alcoholic fatty liver disease (NAFLD).",
    "llama-2-7b-chat-hf_fact_raw": "1. AZD8601 is an inhibitor of the enzyme diacylglycerol acyltransferase 1 (DGAT1).\n2. AZD8601 reduces the synthesis of triacylglycerols in the liver in vivo.\n3. AZD8601 leads to decreased liver triglyceride content.\n4. AZD8601 improves insulin sensitivity in vivo.\n5. AZD8601 has shown potential as a treatment for non-alcoholic fatty liver disease (NAFLD).",
    "llama-2-7b-chat-hf_fact": [
      "AZD8601 is an inhibitor of the enzyme diacylglycerol acyltransferase 1 (DGAT1).",
      "AZD8601 reduces the synthesis of triacylglycerols in the liver in vivo.",
      "AZD8601 leads to decreased liver triglyceride content.",
      "AZD8601 improves insulin sensitivity in vivo.",
      "AZD8601 has shown potential as a treatment for non-alcoholic fatty liver disease (NAFLD)."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: AZD8601 is not an inhibitor of the enzyme diacylglycerol acyltransferase 1 (DGAT1); it is an mRNA-based therapy designed to encode for the protein VEGF-A, which may help in the regeneration of cardiovascular tissues.\n2. UNKNOWN: Without specific data or research findings, it is uncertain whether AZD8601 reduces the synthesis of triacylglycerols in the liver in vivo since it primarily focuses on VEGF-A protein production.\n3. UNKNOWN: Similarly, without specific information, it is unclear whether AZD8601 leads to decreased liver triglyceride content.\n4. UNKNOWN: The impact of AZD8601 on insulin sensitivity in vivo is uncertain without proper context or study results.\n5. FALSE [correction]: AZD8601 is generally associated with cardiovascular therapies due to its mechanism involving VEGF-A, and there is no direct information provided here indicating it has shown potential as a treatment for non-alcoholic fatty liver disease (NAFLD). Further research would be needed to confirm any potential effects on NAFLD.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "llama-2-7b-chat-hf_response": "SAHFS (Splicing-Activating Hyper-Flexible Structures) are created through a process called intron-mediated splicing, where the introns are removed and the exons are spliced together to form a mature RNA molecule. This process involves the binding of splicing factors to the introns and the subsequent cleavage of the introns, allowing the exons to be joined together.",
    "llama-2-7b-chat-hf_fact_raw": "1. SAHFS stands for Splicing-Activating Hyper-Flexible Structures.\n2. SAHFS are created through a process called intron-mediated splicing.\n3. In intron-mediated splicing, introns are removed and exons are spliced together to form a mature RNA molecule.\n4. The process involves the binding of splicing factors to the introns.\n5. The introns are cleaved during the process, allowing the exons to be joined together.",
    "llama-2-7b-chat-hf_fact": [
      "SAHFS stands for Splicing-Activating Hyper-Flexible Structures.",
      "SAHFS are created through a process called intron-mediated splicing.",
      "In intron-mediated splicing, introns are removed and exons are spliced together to form a mature RNA molecule.",
      "The process involves the binding of splicing factors to the introns.",
      "The introns are cleaved during the process, allowing the exons to be joined together."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: SAHFS stands for SINE-Derived Nonautonomous Highly Repetitive Sequences.\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "llama-2-7b-chat-hf_response": "The PDZ domain in SATB1 is involved in protein-protein interactions and plays a role in regulating the localization and activity of SATB1.",
    "llama-2-7b-chat-hf_fact_raw": "1. The PDZ domain in SATB1 is involved in protein-protein interactions.\n2. The PDZ domain plays a role in regulating the localization of SATB1.\n3. The PDZ domain is also involved in regulating the activity of SATB1.",
    "llama-2-7b-chat-hf_fact": [
      "The PDZ domain in SATB1 is involved in protein-protein interactions.",
      "The PDZ domain plays a role in regulating the localization of SATB1.",
      "The PDZ domain is also involved in regulating the activity of SATB1."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: SATB1 does not have a PDZ domain. SATB1 (Special AT-rich sequence-binding protein 1) contains a CUT domain and a homeodomain but not a PDZ domain.\n2. FALSE [correction]: Since SATB1 does not have a PDZ domain, it cannot play a role in regulating the localization of SATB1 through this domain.\n3. FALSE [correction]: Similarly, as SATB1 lacks a PDZ domain, this domain cannot be involved in regulating the activity of SATB1.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "llama-2-7b-chat-hf_response": "The basis of the BLISS technique is the use of a statistical model to predict the binding affinity of a protein for a ligand based on the structure of the protein and the ligand.",
    "llama-2-7b-chat-hf_fact_raw": "1. The BLISS technique uses a statistical model to predict protein-ligand binding affinity. \n2. The prediction by the BLISS technique is based on the structure of the protein and the ligand.",
    "llama-2-7b-chat-hf_fact": [
      "The BLISS technique uses a statistical model to predict protein-ligand binding affinity.",
      "The prediction by the BLISS technique is based on the structure of the protein and the ligand."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. TRUE\n\nThe term \"BLISS technique\" is not a widely recognized term in bioinformatics or structural biology as of my last update, and without specific context, it's difficult to assess the accuracy of the first statement regarding the use of a statistical model. For the second statement, predictions of protein-ligand binding affinity are generally based on the structure of the protein and the ligand, so that statement is true, assuming \"BLISS technique\" refers to a method used for predicting protein-ligand bindings.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true"
    ]
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "llama-2-7b-chat-hf_response": "3 NK3R antagonists are:\n1. A-83-01\n2. A-68-047\n3. L-65-087",
    "llama-2-7b-chat-hf_fact_raw": "1. A-83-01 is a NK3R antagonist.\n2. A-68-047 is a NK3R antagonist.\n3. L-65-087 is a NK3R antagonist.",
    "llama-2-7b-chat-hf_fact": [
      "A-83-01 is a NK3R antagonist.",
      "A-68-047 is a NK3R antagonist.",
      "L-65-087 is a NK3R antagonist."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n\nGiven the specificity of these chemical compounds and their role as NK3R antagonists, without additional context or reference material, it's not possible to confirm the accuracy of these statements.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "llama-2-7b-chat-hf_response": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is BMS-986177.",
    "llama-2-7b-chat-hf_fact_raw": "1. BMS-986177 is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.",
    "llama-2-7b-chat-hf_fact": [
      "BMS-986177 is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n\nWithout access to recent scientific literature or specialized databases that provide information on drug profiles and clinical trials, the statement's accuracy regarding BMS-986177 cannot be verified. The field of pharmacology is rapidly evolving, and new compounds are constantly being developed and tested.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "llama-2-7b-chat-hf_response": "Vaxchora, a cholera vaccine, has been shown to have a protective efficacy of 80-90% against moderate to severe cholera in clinical trials. This means that among individuals who received the vaccine, 80-90% were protected from developing moderate to severe cholera symptoms compared to those who did not receive the vaccine.",
    "llama-2-7b-chat-hf_fact_raw": "1. Vaxchora is a cholera vaccine.\n2. Vaxchora has a protective efficacy of 80-90% against moderate to severe cholera in clinical trials.\n3. The percentage represents the proportion of individuals who received the vaccine and were protected from developing moderate to severe cholera symptoms compared to unvaccinated individuals.",
    "llama-2-7b-chat-hf_fact": [
      "Vaxchora is a cholera vaccine.",
      "Vaxchora has a protective efficacy of 80-90% against moderate to severe cholera in clinical trials.",
      "The percentage represents the proportion of individuals who received the vaccine and were protected from developing moderate to severe cholera symptoms compared to unvaccinated individuals."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "llama-2-7b-chat-hf_response": "The first cholera vaccine approved in the US was the killed oral cholera vaccine (KOCV) developed by the World Health Organization (WHO).",
    "llama-2-7b-chat-hf_fact_raw": "1. The first cholera vaccine approved in the US was a killed oral cholera vaccine (KOCV).\n2. The killed oral cholera vaccine (KOCV) was developed by the World Health Organization (WHO).",
    "llama-2-7b-chat-hf_fact": [
      "The first cholera vaccine approved in the US was a killed oral cholera vaccine (KOCV).",
      "The killed oral cholera vaccine (KOCV) was developed by the World Health Organization (WHO)."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n\n[Note: Without a specific date or reference for the approval of the first cholera vaccine in the US, or detailed information about the development of the killed oral cholera vaccine (KOCV), it is difficult to determine the accuracy of these statements.]",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "llama-2-7b-chat-hf_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is mutations in the X-linked immunoglobulin A (IgA) deficiency gene (Bruton's tyrosine kinase, BTK).",
    "llama-2-7b-chat-hf_fact_raw": "1. Mutations in the Bruton's tyrosine kinase (BTK) gene are the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.",
    "llama-2-7b-chat-hf_fact": [
      "Mutations in the Bruton's tyrosine kinase (BTK) gene are the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Mutations in the Bruton's tyrosine kinase (BTK) gene lead to X-linked agammaglobulinemia (XLA), not common variable immunodeficiency (CVID). The genetic causes of CVID are more diverse and less well-defined, with a range of genetic mutations implicated.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 3743,
    "user_query": "Which is the role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE)?",
    "llama-2-7b-chat-hf_response": "The IFIT1 gene has been associated with Systemic Lupus Erythematosus (SLE) and plays a role in the regulation of autoantibody production.",
    "llama-2-7b-chat-hf_fact_raw": "1. The IFIT1 gene is associated with Systemic Lupus Erythematosus (SLE).\n2. The IFIT1 gene plays a role in the regulation of autoantibody production.",
    "llama-2-7b-chat-hf_fact": [
      "The IFIT1 gene is associated with Systemic Lupus Erythematosus (SLE).",
      "The IFIT1 gene plays a role in the regulation of autoantibody production."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE: The IFIT1 gene, which is involved in immune response, has been found to be associated with Systemic Lupus Erythematosus (SLE) according to some research studies.\n2. UNKNOWN: While the IFIT1 gene is involved in immune response pathways, the direct role it plays in the regulation of autoantibody production, especially in the context of SLE, may be complex and specific information is required to confirm this statement.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown"
    ]
  },
  {
    "id": 3752,
    "user_query": "What is the use of the Liverpool Elbow Score?",
    "llama-2-7b-chat-hf_response": "The Liverpool Elbow Score is a method used to assess the quality of a DNA sample for downstream analyses, such as genotyping or sequencing. It is based on the observation that the elbow region of a DNA ladder, which is a visual representation of the size of DNA fragments, can be used to estimate the quality of the sample. The score is calculated by measuring the distance between the elbow of the ladder and the x-axis, and it ranges from 0 to 1, with higher scores indicating better quality.",
    "llama-2-7b-chat-hf_fact_raw": "1. The Liverpool Elbow Score is used to assess the quality of a DNA sample.\n2. It is utilized for downstream analyses like genotyping or sequencing.\n3. The method is based on the observation of the elbow region of a DNA ladder.\n4. The score is calculated by measuring the distance between the elbow of the ladder and the x-axis.\n5. The score ranges from 0 to 1, with higher scores indicating better quality.",
    "llama-2-7b-chat-hf_fact": [
      "The Liverpool Elbow Score is used to assess the quality of a DNA sample.",
      "It is utilized for downstream analyses like genotyping or sequencing.",
      "The method is based on the observation of the elbow region of a DNA ladder.",
      "The score is calculated by measuring the distance between the elbow of the ladder and the x-axis.",
      "The score ranges from 0 to 1, with higher scores indicating better quality."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The Liverpool Elbow Score is not used to assess the quality of a DNA sample; it is actually used to assess elbow function in patients, particularly after trauma or surgery.\n2. FALSE [correction]: Since the Liverpool Elbow Score is not used for DNA samples, it is not utilized for downstream analyses like genotyping or sequencing. Those processes use different methods to assess DNA quality.\n3. FALSE [correction]: The method is not based on the observation of the elbow region of a DNA ladder; the Liverpool Elbow Score involves the assessment of elbow function in clinical settings.\n4. FALSE [correction]: The score is not calculated by measuring the distance between the elbow of a ladder and the x-axis as it is not related to DNA analysis. The Liverpool Elbow Score involves clinical evaluation parameters.\n5. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3763,
    "user_query": "Describe efforts on Sarcoma from the 100,000 Genomes Project",
    "llama-2-7b-chat-hf_response": "The 100,000 Genomes Project is an ambitious initiative aimed at analyzing the genomes of 100,000 individuals, including those with rare and aggressive cancers such as sarcoma. The project has led to significant advancements in our understanding of the genetic mutations driving sarcoma development and progression. For instance, researchers have identified novel driver mutations in sarcoma subtypes, including chondrosarcoma and leiomyosarcoma. These findings have implications for the development of targeted therapies and improved patient outcomes. Additionally, the project has shed light on the complex interplay between genetic and epigenetic alterations in sarcoma, highlighting potential new therapeutic targets. Overall, the 100,000 Genomes Project has greatly enhanced our understanding of sarcoma biology and paved the way for more effective diagnosis and treatment.",
    "llama-2-7b-chat-hf_fact_raw": "1. The 100,000 Genomes Project aims to analyze the genomes of 100,000 individuals.\n2. The project includes individuals with rare and aggressive cancers, such as sarcoma.\n3. Researchers have identified novel driver mutations in sarcoma subtypes like chondrosarcoma and leiomyosarcoma through the project.\n4. The 100,000 Genomes Project has contributed to the understanding of the genetic mutations driving sarcoma development and progression.\n5. The initiative has revealed the complex relationship between genetic and epigenetic alterations in sarcoma.",
    "llama-2-7b-chat-hf_fact": [
      "The 100,000 Genomes Project aims to analyze the genomes of 100,000 individuals.",
      "The project includes individuals with rare and aggressive cancers, such as sarcoma.",
      "Researchers have identified novel driver mutations in sarcoma subtypes like chondrosarcoma and leiomyosarcoma through the project.",
      "The 100,000 Genomes Project has contributed to the understanding of the genetic mutations driving sarcoma development and progression.",
      "The initiative has revealed the complex relationship between genetic and epigenetic alterations in sarcoma."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN\n\nStatement 3 is UNKNOWN without specific details from research findings or publication data to confirm the identification of novel driver mutations in those sarcoma subtypes through the 100,000 Genomes Project. Similarly, statement 5 is UNKNOWN as it implies detailed scientific findings that are not verified in the given context.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3777,
    "user_query": "Does protein ALEX1 contain armadillo repeats?",
    "llama-2-7b-chat-hf_response": "Yes, protein ALEX1 does contain armadillo repeats.",
    "llama-2-7b-chat-hf_fact_raw": "1. Protein ALEX1 contains armadillo repeats.",
    "llama-2-7b-chat-hf_fact": [
      "Protein ALEX1 contains armadillo repeats."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN \n\n[Explanation]: The given statement about Protein ALEX1 containing armadillo repeats cannot be verified as true or false without additional context or specific knowledge about the protein's structure. Armadillo repeats are a type of protein domain found in many proteins but without a specific reference to Protein ALEX1's characterization, this statement cannot be confirmed or denied.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3789,
    "user_query": "List enzymes that removes histone modifications.",
    "llama-2-7b-chat-hf_response": "1. Histone demethylases remove methyl groups from histone proteins, leading to changes in chromatin structure and gene expression.\n2. Histone acetyltransferases (HATs) add acetyl groups to histone proteins, leading to changes in chromatin structure and gene expression.\n3. Histone deacetylases (HDACs) remove acetyl groups from histone proteins, leading to changes in chromatin structure and gene expression.\n4. Histone ubiquitin ligases remove ubiquitin from histone proteins, leading to changes in chromatin structure and gene expression.\n5. Histone phosphatases remove phosphate groups from histone proteins, leading to changes in chromatin structure and gene expression.",
    "llama-2-7b-chat-hf_fact_raw": "1. Histone demethylases remove methyl groups from histone proteins.\n2. Histone deacetylases (HDACs) remove acetyl groups from histone proteins.\n3. Histone ubiquitin ligases remove ubiquitin from histone proteins.\n4. Histone phosphatases remove phosphate groups from histone proteins.",
    "llama-2-7b-chat-hf_fact": [
      "Histone demethylases remove methyl groups from histone proteins.",
      "Histone deacetylases (HDACs) remove acetyl groups from histone proteins.",
      "Histone ubiquitin ligases remove ubiquitin from histone proteins.",
      "Histone phosphatases remove phosphate groups from histone proteins."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Histone ubiquitin ligases add ubiquitin to histone proteins. The removal of ubiquitin from histone proteins is typically performed by deubiquitinating enzymes (DUBs).\n4. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3806,
    "user_query": "Does head ct increase brain tumor risk?",
    "llama-2-7b-chat-hf_response": "No, head CT scans do not increase the risk of brain tumors.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3809,
    "user_query": "Which type of pluripotency is Otx2 associated with?",
    "llama-2-7b-chat-hf_response": "Otx2 is associated with naive pluripotency.",
    "llama-2-7b-chat-hf_fact_raw": "1. Otx2 is associated with naive pluripotency.",
    "llama-2-7b-chat-hf_fact": [
      "Otx2 is associated with naive pluripotency."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 3815,
    "user_query": "How many DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region?",
    "llama-2-7b-chat-hf_response": "12 DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region.",
    "llama-2-7b-chat-hf_fact_raw": "1. There are 12 DNaseI hypersensitive sites marking the murine beta globin locus region.",
    "llama-2-7b-chat-hf_fact": [
      "There are 12 DNaseI hypersensitive sites marking the murine beta globin locus region."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN\n\nThe number of DNaseI hypersensitive sites marking the murine beta globin locus region is not a widely known fact and would require specific knowledge in genetics and molecular biology. Without access to the relevant scientific literature or specific passage that contains this information, the accuracy of this statement cannot be determined.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3822,
    "user_query": "List as many European influenza vaccines as possible.",
    "llama-2-7b-chat-hf_response": "Some European influenza vaccines include:\n- Fluad (Aggamemnon/Flucelvax)\n- Fluarix (GSK)\n- Fluvir (Baxter)\n- Fluad (Aggamemnon/Flucelvax)\n- Flu-vax (Sanofi)\n- Flu-vax (Novartis)\n- Flu-vax (GlaxoSmithKline)",
    "llama-2-7b-chat-hf_fact_raw": "1. Fluad is a brand name for an influenza vaccine.\n2. Fluarix is an influenza vaccine produced by GSK (GlaxoSmithKline).\n3. Fluvir is an influenza vaccine produced by Baxter.\n4. Sanofi produces an influenza vaccine under the name Flu-vax.\n5. Novartis produces an influenza vaccine also under the name Flu-vax.",
    "llama-2-7b-chat-hf_fact": [
      "Fluad is a brand name for an influenza vaccine.",
      "Fluarix is an influenza vaccine produced by GSK (GlaxoSmithKline).",
      "Fluvir is an influenza vaccine produced by Baxter.",
      "Sanofi produces an influenza vaccine under the name Flu-vax.",
      "Novartis produces an influenza vaccine also under the name Flu-vax."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Fluvir is an antiviral medication used for the treatment of influenza, not an influenza vaccine.\n4. FALSE [correction]: Sanofi produces an influenza vaccine under the name Fluzone.\n5. FALSE [correction]: Fluvax is a brand name of an influenza vaccine produced by Seqirus, not Novartis. Novartis previously had influenza vaccines but sold its flu vaccine business to CSL, which operates as Seqirus.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3832,
    "user_query": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "llama-2-7b-chat-hf_response": "Yes, the Paramyxovirus geneome is segmented, negative-sense RNA.",
    "llama-2-7b-chat-hf_fact_raw": "1. The Paramyxovirus genome is segmented.\n2. The Paramyxovirus genome is negative-sense RNA.",
    "llama-2-7b-chat-hf_fact": [
      "The Paramyxovirus genome is segmented.",
      "The Paramyxovirus genome is negative-sense RNA."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The Paramyxovirus genome is non-segmented.\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true"
    ]
  },
  {
    "id": 3869,
    "user_query": "Roflumilast Cream is effective for which disease?",
    "llama-2-7b-chat-hf_response": "Roflumilast cream is effective for the treatment of plaque psoriasis.",
    "llama-2-7b-chat-hf_fact_raw": "1. Roflumilast cream is used for the treatment of plaque psoriasis.",
    "llama-2-7b-chat-hf_fact": [
      "Roflumilast cream is used for the treatment of plaque psoriasis."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Roflumilast is available in different formulations, including as a cream, but it is primarily known for being developed as an oral tablet used to treat chronic obstructive pulmonary disease (COPD). For the treatment of plaque psoriasis, roflumilast is formulated as a topical cream. Thus, it is not incorrect to say that a roflumilast cream could be used for plaque psoriasis; however, the known primary use of roflumilast is for COPD. Without additional context confirming that the roflumilast in question is indeed the cream formulation specifically for psoriasis, the original statement may be misleading.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 3885,
    "user_query": "Which tools have been developed for identifying and visualising ncRNA promoters?",
    "llama-2-7b-chat-hf_response": "Tools that have been developed for identifying and visualizing non-coding RNA (ncRNA) promoters include tools such as CpGplot, which uses a Bayesian approach to identify and visualize ncRNA promoters based on CpG dinucleotides, and tools such as RNAhybrid, which uses a hidden Markov model to identify and visualize ncRNA promoters based on RNA secondary structure.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3918,
    "user_query": "List example genes that SWIM tool has identified and which are down-regulated in glioblastoma",
    "llama-2-7b-chat-hf_response": "The SWIM tool has identified several genes that are down-regulated in glioblastoma, including genes such as TP53, PTEN, and CDKN2A.",
    "llama-2-7b-chat-hf_fact_raw": "1. The SWIM tool has identified the TP53 gene as being down-regulated in glioblastoma.\n2. The SWIM tool has identified the PTEN gene as being down-regulated in glioblastoma.\n3. The SWIM tool has identified the CDKN2A gene as being down-regulated in glioblastoma.",
    "llama-2-7b-chat-hf_fact": [
      "The SWIM tool has identified the TP53 gene as being down-regulated in glioblastoma.",
      "The SWIM tool has identified the PTEN gene as being down-regulated in glioblastoma.",
      "The SWIM tool has identified the CDKN2A gene as being down-regulated in glioblastoma."
    ],
    "llama-2-7b-chat-hf_judge_raw": "Response:\n1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n\nRationale: The SWIM (Subnetwork Integration and Modeling) tool is a bioinformatics tool used for analyzing complex cancer genomics data. Without specific data or conclusions from a study utilizing the SWIM tool, it's impossible to verify the accuracy of these statements. The statements would require validation from scientific literature or data outputs from the SWIM tool to confirm if the TP53, PTEN, or CDKN2A genes are indeed down-regulated in glioblastoma.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3926,
    "user_query": "Which R packages have been developed for studying TADs?",
    "llama-2-7b-chat-hf_response": "R packages such as TADbit, TADtrack, and TADmap have been developed for studying TADs.",
    "llama-2-7b-chat-hf_fact_raw": "1. TADbit is an R package developed for studying TADs.\n2. TADtrack is an R package developed for studying TADs.\n3. TADmap is an R package developed for studying TADs.",
    "llama-2-7b-chat-hf_fact": [
      "TADbit is an R package developed for studying TADs.",
      "TADtrack is an R package developed for studying TADs.",
      "TADmap is an R package developed for studying TADs."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: As of my knowledge cutoff in 2023, TADtrack is not a recognized R package for studying TADs. However, without more context, I cannot provide the correct name of an R package supposed to replace TADtrack.\n3. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3927,
    "user_query": "Which bioconductor tool has been developed for accessing bacterial regulatory networks?",
    "llama-2-7b-chat-hf_response": "The Bioconductor tool developed for accessing bacterial regulatory networks is called \"BioCyc\".",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3933,
    "user_query": "What are the end products of the shikimate pathway?",
    "llama-2-7b-chat-hf_response": "The end products of the shikimate pathway are aromatic amino acids, including phenylalanine, tyrosine, and tryptophan.",
    "llama-2-7b-chat-hf_fact_raw": "1. The shikimate pathway produces aromatic amino acids.\n2. Phenylalanine is an end product of the shikimate pathway.\n3. Tyrosine is an end product of the shikimate pathway.\n4. Tryptophan is an end product of the shikimate pathway.",
    "llama-2-7b-chat-hf_fact": [
      "The shikimate pathway produces aromatic amino acids.",
      "Phenylalanine is an end product of the shikimate pathway.",
      "Tyrosine is an end product of the shikimate pathway.",
      "Tryptophan is an end product of the shikimate pathway."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3936,
    "user_query": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "llama-2-7b-chat-hf_response": "Yes, cabergoline is used to treat Nelson's syndrome, a rare condition that can occur after treatment with dopamine agonists, including cabergoline.",
    "llama-2-7b-chat-hf_fact_raw": "1. Cabergoline is used to treat Nelson's syndrome.\n2. Nelson's syndrome is a rare condition.\n3. Nelson's syndrome can occur after treatment with dopamine agonists.",
    "llama-2-7b-chat-hf_fact": [
      "Cabergoline is used to treat Nelson's syndrome.",
      "Nelson's syndrome is a rare condition.",
      "Nelson's syndrome can occur after treatment with dopamine agonists."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Cabergoline is not used to treat Nelson's syndrome. It is typically used to treat conditions associated with hyperprolactinemia, like prolactinomas. Nelson's syndrome is associated with the rapid growth of an ACTH-producing pituitary tumor after bilateral adrenalectomy for Cushing's disease.\n2. TRUE\n3. FALSE [correction]: Nelson's syndrome can occur after bilateral adrenalectomy for Cushing's disease, not after treatment with dopamine agonists. Dopamine agonists are used to treat conditions related to high prolactin levels, not Nelson's syndrome.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3939,
    "user_query": "What is the main manifestation of Liebenberg syndrome?",
    "llama-2-7b-chat-hf_response": "The main manifestation of Liebenberg syndrome is a distinctive facial appearance, including a short, broad nose and a prominent lower jaw.",
    "llama-2-7b-chat-hf_fact_raw": "1. Liebenberg syndrome is characterized by a distinctive facial appearance.\n2. A short, broad nose is a manifestation of Liebenberg syndrome.\n3. A prominent lower jaw is a manifestation of Liebenberg syndrome.",
    "llama-2-7b-chat-hf_fact": [
      "Liebenberg syndrome is characterized by a distinctive facial appearance.",
      "A short, broad nose is a manifestation of Liebenberg syndrome.",
      "A prominent lower jaw is a manifestation of Liebenberg syndrome."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n\nThe provided statements refer to Liebenberg syndrome, which is not a widely recognized or documented medical condition in widely available scientific literature as of my last update. Therefore, without specific and credible sources to verify the characteristics of the purported syndrome, it is not possible to ascertain the truthfulness of these statements.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3977,
    "user_query": "List orally bioavailable MPS1 kinase inhibitors",
    "llama-2-7b-chat-hf_response": "",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 4031,
    "user_query": "Was golimumab tested for diabetes?",
    "llama-2-7b-chat-hf_response": "No, golimumab was not tested for diabetes.",
    "llama-2-7b-chat-hf_fact_raw": "1. Golimumab was not tested for diabetes.",
    "llama-2-7b-chat-hf_fact": [
      "Golimumab was not tested for diabetes."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN \n\nSince there is no specific context given other than the statement itself, I cannot verify if Golimumab was tested for diabetes. Golimumab is typically used as a treatment for certain autoimmune conditions, and without additional information, it is not possible to give a true or false answer regarding its testing for diabetes.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 4055,
    "user_query": "Is progeria caused by an autosomal recessive gene?",
    "llama-2-7b-chat-hf_response": "Yes.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 4082,
    "user_query": "What are common variants at 12q14 and 12q24 associated with?",
    "llama-2-7b-chat-hf_response": "12q14 and 12q24 are associated with an increased risk of developing breast cancer.",
    "llama-2-7b-chat-hf_fact_raw": "1. 12q14 is associated with an increased risk of developing breast cancer.\n2. 12q24 is associated with an increased risk of developing breast cancer.",
    "llama-2-7b-chat-hf_fact": [
      "12q14 is associated with an increased risk of developing breast cancer.",
      "12q24 is associated with an increased risk of developing breast cancer."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n\nWithout specific genetic or medical context, the statements about 12q14 and 12q24 being associated with an increased risk of developing breast cancer are not possible to confirm or correct accurately. These statements would require specific scientific evidence or research references that associate these chromosomal regions with breast cancer risk.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4096,
    "user_query": "Which are the ligands of the Roundabout (Robo) receptors?",
    "llama-2-7b-chat-hf_response": "The ligands of the Roundabout (Robo) receptors are the ephrins.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 4112,
    "user_query": "Is there a role for TFII-I in megakaryopoiesis?",
    "llama-2-7b-chat-hf_response": "Yes, TFII-I plays a role in megakaryopoiesis.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 4145,
    "user_query": "Is atenolol metabolized by CYP2D6?",
    "llama-2-7b-chat-hf_response": "Yes, atenolol is metabolized by CYP2D6.",
    "llama-2-7b-chat-hf_fact_raw": "1. Atenolol is metabolized by CYP2D6.",
    "llama-2-7b-chat-hf_fact": [
      "Atenolol is metabolized by CYP2D6."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Atenolol is not significantly metabolized by the liver and does not undergo significant metabolism by CYP2D6. It is primarily excreted unchanged in urine.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 4158,
    "user_query": "List versions of ExpansionHunter",
    "llama-2-7b-chat-hf_response": "1. ExpansionHunter 1.0: The first version of ExpansionHunter, which introduced the concept of using deep learning to predict gene fusions from RNA-seq data.\n2. ExpansionHunter 2.0: The second version of ExpansionHunter, which improved the accuracy of gene fusion predictions by incorporating additional features such as splicing information.\n3. ExpansionHunter 3.0: The third version of ExpansionHunter, which introduced a new deep learning architecture and improved the speed and accuracy of gene fusion predictions.\n4. ExpansionHunter 4.0: The fourth version of ExpansionHunter, which incorporated new features such as improved splicing information and better handling of complex fusion events.\nThese are just a few versions of ExpansionHunter.",
    "llama-2-7b-chat-hf_fact_raw": "1. ExpansionHunter 1.0 was the first version of ExpansionHunter and used deep learning to predict gene fusions from RNA-seq data.\n2. ExpansionHunter version 2.0 included improvements in the accuracy of gene fusion predictions by incorporating splicing information.\n3. In ExpansionHunter 3.0, a new deep learning architecture was introduced.\n4. ExpansionHunter 4.0 brought new features to better handle complex fusion events and improved splicing information.",
    "llama-2-7b-chat-hf_fact": [
      "ExpansionHunter 1.0 was the first version of ExpansionHunter and used deep learning to predict gene fusions from RNA-seq data.",
      "ExpansionHunter version 2.0 included improvements in the accuracy of gene fusion predictions by incorporating splicing information.",
      "In ExpansionHunter 3.0, a new deep learning architecture was introduced.",
      "ExpansionHunter 4.0 brought new features to better handle complex fusion events and improved splicing information."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: ExpansionHunter is a software tool designed to analyze types of genetic variation known as repeat expansions, not gene fusions from RNA-seq data.\n2. UNKNOWN: Without additional context on the specific features of ExpansionHunter 2.0, it is not possible to verify the improvements made in the accuracy of any predictions, including those referring to gene fusions or repeat expansions.\n3. UNKNOWN: It is unclear whether ExpansionHunter 3.0 introduced a new deep learning architecture without more specific information about the version's features.\n4. UNKNOWN: The improvements and new features in ExpansionHunter 4.0 cannot be determined without more information regarding the version's updates.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4164,
    "user_query": "What is the role of Adamts18 in hormone receptor signaling?",
    "llama-2-7b-chat-hf_response": "Adamts18 is a protease that cleaves and inhibits the activity of several hormone receptors, including the estrogen receptor alpha and the progesterone receptor.",
    "llama-2-7b-chat-hf_fact_raw": "1. Adamts18 is a protease.\n2. Adamts18 cleaves and inhibits the activity of several hormone receptors.\n3. Adamts18 affects the estrogen receptor alpha.\n4. Adamts18 affects the progesterone receptor.",
    "llama-2-7b-chat-hf_fact": [
      "Adamts18 is a protease.",
      "Adamts18 cleaves and inhibits the activity of several hormone receptors.",
      "Adamts18 affects the estrogen receptor alpha.",
      "Adamts18 affects the progesterone receptor."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: While ADAMTS18 is indeed a protease, it is known to be involved in various physiological processes, but there is no specific evidence to suggest it cleaves and inhibits the activity of several hormone receptors. More context is needed to affirm this general statement as ADAMTS proteases often have specific substrates and functions.\n3. UNKNOWN: Without specific context, it's difficult to confirm whether ADAMTS18 affects the estrogen receptor alpha. This would require specific scientific evidence.\n4. UNKNOWN: Similar to the previous statement, it's difficult to ascertain whether ADAMTS18 affects the progesterone receptor without more detailed scientific context or evidence.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4208,
    "user_query": "What is the mode of action of Thiazovivin?",
    "llama-2-7b-chat-hf_response": "Thiazovivin is a DNA-binding agent that inhibits the activity of histone deacetylases (HDACs), which are enzymes that play a role in epigenetic regulation of gene expression.",
    "llama-2-7b-chat-hf_fact_raw": "1. Thiazovivin is a DNA-binding agent.\n2. Thiazovivin inhibits the activity of histone deacetylases (HDACs).\n3. Histone deacetylases (HDACs) are enzymes involved in epigenetic regulation of gene expression.",
    "llama-2-7b-chat-hf_fact": [
      "Thiazovivin is a DNA-binding agent.",
      "Thiazovivin inhibits the activity of histone deacetylases (HDACs).",
      "Histone deacetylases (HDACs) are enzymes involved in epigenetic regulation of gene expression."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Thiazovivin is not a DNA-binding agent; it is a small molecule inhibitor that enhances the survival of human pluripotent stem cells.\n2. FALSE [correction]: Thiazovivin does not inhibit the activity of histone deacetylases (HDACs); it is instead a selective inhibitor of the Rho-associated kinase (ROCK).\n3. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false",
      "true"
    ]
  }
]